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ABSTRACT 
Many HIV positive patients are on antiretroviral therapy (ART) to assist in decreasing the 
replication of the HIV virus within the body. Adherence to this medication is important, as 
non- adherence can have serious repercussions. Therefore, the patients’ knowledge of ART 
and their disease is crucial in ensuring good adherence. 
A range of barriers to patient education were suspected by the researcher in this community 
of Delft. The high influx of patients into the clinic everyday minimized consultation time and 
thereby diminished the opportunity for effective patient education. Consequently, adherence 
to medication which is closely related to the knowledge and understanding of patients about 
the disease may be affected.  
The following research question was therefore explored: What is the knowledge of infected 
HIV/AIDS patients who are receiving antiretroviral treatment about HIV/AIDS and ART? The 
objectives set were to evaluate the patient’s knowledge of HIV/AIDS, evaluate the 
knowledge of ART and to determine whether there are statistical differences between the 
dependant and independent variables within the study. A quantitative descriptive  
correlational research design was applied and a convenience sample of n= 200 (8.5%) 
patients was selected from a population of N= 2349 at the Delft Community Health Centre.  
A multiple choice questionnaire comprising of mainly closed ended questions with multiple 
responses was used in individual interviews conducted by either the researcher or 
fieldworker. Reliability and validity was ensured through the consultation of experts in the 
fields of research methodology, statistics, HIV/AIDS and the Health Research Ethics 
Committee of Stellenbosch University. 
Permission to conduct this study was granted by the Health Research Ethics Committee of 
Stellenbosch University, the Provincial Regional Head for Primary Health Care Services, as 
well as the head of the Delft Community Health Centre. 
Data revealed that the participants were mainly female (n=145/72.5%), and the mean age 
was 37.5 years. Participants were mostly Xhosa speaking and literate, and the majority 
(n=112/56%), of the participants had a highest education level between grade 9 and grade 
12. Many (n=73/36.5%) of the participants had been living with HIV for more than 5 years, 
but had been on ART for between 1 to 3 years. Knowledge was assessed by asking 
questions about various aspects of HIV and ART throughout the study. Scores for the 14 
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critical questions revealed that (n=0/0%) of the participants had good knowledge, 
(n=40/20%) of the participants had average knowledge and (n=160/80%) of the participants 
had poor knowledge. The average score for all participants for all 20 knowledge testing 
questions was (12.6/63%). 
The findings showed that the overall knowledge (n=160/80%) is poor. Basic terms and 
principles of HIV/AIDS and ART were not understood and serious misconceptions regarding 
the disease were revealed.  
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OPSOMMING 
 
Baie MIV positiewe pasiënte is op antiretrovirale terapie (ART) om te help met die 
vermindering van die replisering van die HIV virus in die liggaam. Gebruik van hierdie 
medikasie is belangrik omdat versuiming van inname ernstige gevolge kan hê. Dus, is die 
pasiënte se kennis van ART en hul siekte van deurslaggewende belang om volgehoue 
inname te verseker. 
’n Reeks van hindernisse om pasiënte te onderrig, is deur die navorser in die 
Delftgemeenskap vermoed. Die hoë toestroming van pasiënte na die kliniek elke dag het die 
konsultasietyd tot die minimum beperk en daardeur die geleentheid vir effektiewe 
pasiëntonderrig laat verminder. Gevolglik, kan die nakoming om die medikasie te neem wat 
’n noue verband toon met die kennis en begrip wat pasiënte het oor die siekte, geaffekteer 
word. 
Die volgende navorsingsvraag is gevolglik ondersoek: Wat is die kennis van geïnfekteerde 
HIV/VIGS pasiënte wat antiretrovirale behandeling ontvang oor HIV/VIGS en ART? Die 
doelwitte wat gestel is, is om die pasiënt se kennis van HIV/VIGS te evalueer, die kennis van 
ART te evalueer en te bepaal of daar ’n statistiese verwantskap tussen onafhanklike en 
afhanklike veranderlikes binne die studie is. ’n Kwantitatiewe beskrywende korrelerende 
navorsingsontwerp is toegepas en ’n gerieflikheidsmonster van n= 200 (8.5%) pasiënte is 
geselekteer uit ’n bevolking van N = 2349 by die Delftgemeenskap Gesondheidssentrum. 
’n Veelkeusige vraelys wat hoofsaaklik uit geslote vrae met veelkeusige response bestaan 
het, is gebruik in individuele onderhoude wat deur of die navorser of veldwerker gevoer is. 
Betroubaarheid en geldigheid is verseker deur oorlegpleging met spesialiste op die gebied 
van navorsingsmetodologie, statistiek, HIV/VIGS en die Gesondheidsnavorsing se Etiese 
Komitee van die Universiteit van Stellenbosch. 
Toestemming om die navorsing te doen, is gegee deur die Gesondheidsnavorsing se Etiese 
Komitee van Stellenbosch Universiteit, die Provinsiale Streekshoof vir Primêre 
Gesondheidsdienste, asook die hoof van die Delftgemeenskap Gesondheidssentrum. 
Data het bewys dat die deelnemers hoofsaaklik vroulik is (n=145/72.5%) en die gemiddelde 
ouderdom 37.5 jaar. Deelnemers is meestal Xhosasprekend en geletterd en die 
meerderheid (n=112/56%) van die deelnemers se hoogste opleidingsvlak is tussen graad 9 
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en graad 12. Baie (n=73/36.5%) van die deelnemers het met HIV geleef vir 5 jaar, maar was 
op ART vir tussen 1 tot 3 jaar. Kennis is geassesseer deur vrae te stel oor verskeie aspekte 
van HIV en ART dwarsdeur die ondersoek. Puntetelling vir die 14 kritiese vrae het aan die lig 
gebring dat (n=0/0%) van die deelnemers goeie kennis het, (n=40/20%) van die deelnemers 
beskik oor gemiddelde kennis en (n=160/80%) van die deelnemers se kennis is gering. Die 
gemiddelde puntetelling vir al die deelnemers van al 20 kennisvrae wat getoets is, is 
(12.6/63%). 
Die bevindinge bewys dat die algehele kennis (n= 160/80%) gering is. Basiese terminologie 
en beginsels van HIV/VIGS en ART word nie begryp nie en ernstige wanopvattinge 
aangaande die siekte is geopenbaar. 
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CHAPTER 1: SCIENTIFIC FOUNDATION FOR THE STUDY 
1.1 BACKGROUND  
The Human Immunodeficiency Virus (HIV) is primarily a sexually transmitted disease which 
has changed the focus of health care delivery in South Africa dramatically since the 1980’s.  
According to the 2009 AIDS Epidemic update, there were 5.7 million people living with 
HIV/AIDS in South Africa, out of a global total of 33.4 million. This update therefore indicates 
that South Africa constitutes 17% of the global HIV/AIDS population. The number of people 
living with HIV/AIDS has shown a constant increase every year since the first diagnosis of 
HIV/AIDS in the 1980’s despite the call for better co-ordination and monitoring (South Africa, 
2007:11).  Various interventions have been introduced to reduce vulnerability to HIV 
infection and the impact of AIDS including: 
 prevention of the sexual transmission of HIV through distribution of free condoms,  
 increase in coverage for voluntary counselling and testing and   
 promotion of regular HIV testing  
(South Africa, 2007:13-14). 
According to the HIV and AIDS and STI strategic plan for South Africa (2007:19), South 
Africa’s main contributing factors in the spread of this disease are rooted in poverty, 
underdevelopment, the low status of woman and gender-based violence in the communities. 
It is assumed that adherence is directly related to knowledge, amongst other factors (Kip, 
Ehlers, Van der Wal, 2008:152). By patients’ understanding of their disease, it is more likely 
that they will adhere to the education they are given regarding, how the HI-virus is 
transmitted and how this can be prevented, what the virus does in the body, how HIV can be 
treated, how the treatment affects the virus, what the side effects of treatment are and the 
risks of poor adherence.  
The standard treatment of choice for people living with HIV/AIDS is antiretroviral therapy 
(ART). The pharmacological action of this medication is to suppress the replication of the HI 
virus (South Africa, 2010:28). Adherence to ART is therefore important to contain the 
disease because poor adherence may produce serious complications like medication 
resistance, which could even lead to death.  
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The virus is transmitted through the exchange of bodily fluids during sexual intercourse, 
blood transmission, mother to child transmission (MTCT) as in during pregnancy, birth and 
breast feeding (Evian, 2008:13-17). The underlying pathophysiology which results when the 
HIV virus enters the body is to destroy or cause dysfunction in the helper T cells or CD4 
cells, which are known as the immune response cells in the body (Evian, 2008:7). These 
cells are required to signal the immune system to any pathogens which enter the body which 
may result in a disturbance of the normal physiology of the body. The body may respond 
with signs of infection.  
Unfortunately, there is still no cure for HIV/AIDS, but antiretroviral therapy (ART), is the 
treatment of choice to contain the disease. In layman’s terms, ART suppresses the virus and 
thereby prevents the cells to ‘make copies’ or ‘replicate’ themselves (Evian, 2008:79). ART 
therefore lowers the viral load of the HIV in the blood, and by doing so prevents CD4 cells 
from being destroyed. 
1.2  RATIONALE 
Many HIV positive patients are on ART to assist in decreasing the replication of the HI-virus 
within the body. Adherence to this medication is of crucial importance, as serious side 
effects can be caused by non-adherence. Therefore, the patient’s knowledge of ART and 
HIV disease is crucial to ensure that adherence is improved and maintained. 
Adherence can be defined as, ‘the process in which a person follows rules, guidelines or 
standards especially as a patient follows a prescription and recommendations for a regimen  
of care.’ (Anderson, Keith, Novak & Elliot, 2002:42).  
According to Bangsberg (2006:939), adherence of more than 90% needs to be achieved, in 
order for ART to be effective. If ART is not correctly adhered to, the HIV virus is not optimally 
controlled within the body and the viral load in the blood increases. 
HIV is known to rapidly spread by multiplying itself; therefore this uncontrolled virus 
replicates itself within the body if not adequately suppressed by lifelong ART, which could 
lead to resistance to medication (Evian, 2008:79).  
According to previous studies adherence rates are not optimal. In a study conducted by 
Bhat, Ramburuth, Singh, Titi, Antony, Chiya, Irusen, Mtyapi, Mofoka, Zibeke, Chere-Sao, 
Gwadiso, Sethathi, Mbondwana, & Msengana (2010:948), the results indicated that only 
62.5% had an adherence rate of more than 90% and therefore 37.5% of the participants 
were at risk of developing resistance due to unacceptable adherence levels. 
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In a study conducted in Botswana, adherence rates were strongly influenced by 
misconceptions regarding the virus. Out of 400 participants, male and female, 40.3% did not 
believe that they could be re-infected with HIV/AIDS through sexual intercourse or other 
means. Another misconception is that some people believe that HIV could be cured by ART. 
In the same study it was indicated that 9.3% of the participants believed that HIV did not 
really even exist (Kip, Ehlers, Van der Wal, 2008:152). 
A study conducted in Soweto, South Africa, revealed that just below 60% of the participants 
believed that HIV could be transmitted through mosquitoes (Nachega, Lehman, Hlatshwayo, 
Mothopeng, Chaisson, Kardtaedt., 2005:189). In Brazil, Almeida and Vieira (2009:184) 
showed in their studies that 55% of the HIV positive participants on ART did not know the 
mode of action of the antiretrovirals (ARV’s) in suppressing the virus and preventing rapid 
replication. The study also indicated that 36% did not know that they would be taking 
medication for life, and only 14% of the participants knew and gave the correct answer on 
what to do if a dose is skipped.  
Nachega et al. (2005:189), in their studies conducted in Soweto revealed a relatively high 
understanding of HIV disease progression and transmission by the participants, as well as 
the importance of adherence to medication. This could be attributed to the fact that the study 
took place in a specialized HIV treatment clinic within the township, where all patients were 
HIV positive. Nevertheless, this indicates that there was much attention given to maintaining 
a high level of patient education and ensuring patient understanding in this facility, which is 
reassuring. 
Molassiotis, Nahas-Lopez, Chung, Lam, Li, Lau (2002:305), revealed the importance and 
value of regular and ongoing patient education, in their study conducted in China. This study 
found a 97% adherence rate. Patients who participated in the study showed good knowledge 
and understanding concerning medication and related knowledge regarding the importance 
of drug resistance and decreasing the risk of drug resistance. These patients all received 
regular individual patient education regarding their illness and the researchers identified that 
there was strong trusting relationship between the patients and the nursing staff. 
The above studies show that, by providing regular education by healthcare professionals to 
patients, the better the understanding the patients will have of their disease. With an 
improved understanding, insight and knowledge about the disease and management, 
thereof, an improvement in adherence may result.  
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Patients may adhere to education given to them regarding preventing HIV transmission 
through safe sex practices, taking medication as prescribed and taking responsibility for their 
own health. It is important for patients to understand the importance of attending all follow-up 
appointments, understanding and having their CD4 and viral loads monitored regularly.  
Knowledge and understanding of HIV/AIDS will in turn reduce the amount of HIV cases in 
the community, in the country and eventually globally. However, as experienced by the 
researcher in practice, serious misconceptions also exist in communities about HIV/AIDS as 
described above which may influence adherence to medication. 
Furthermore, overcrowded clinics aggravate the management of patients daily. An average 
number of 1200 patients attend a particular comprehensive health clinic daily with a variety 
of conditions. The researcher in her daily practice as a primary health care practitioner 
observed that due to a minimal number of nursing and medical staff, health education given 
to especially patients faced with a debilitating disease such as HIV/AIDS are inadequate. 
This is very serious as a lack of knowledge and understanding will lead to ignorance and will 
maintain the rapid spread of HIV/AIDS in South Africa. 
According to Kozier, Erb, Berman and Burke (2000:461), emotions, prognosis, language and 
culture are factors inhibiting patients from learning. Emotions such as fear, anger, 
depression and anxiety result in an inability of the patients to concentrate and focus on what 
they are being educated about. If patients are preoccupied by their prognosis, they will not 
concentrate on the information being conveyed to them and if they do not understand what is 
being said due to a language barrier, the education given will therefore be unprofitable. 
Cultural barriers may have an important effect on learning. Values of the Western culture 
may be in conflict with the cultural values of these patients and lead to poor adherence to 
advice and treatment offered or recommended. 
The researcher observed that there were a range of suspected barriers to patient education 
in this community. The high influx of patients daily into the clinic minimizes consultation time 
and thereby diminishes the opportunity for effective patient education regarding HIV/AIDS. 
Possible illiteracy of the HIV positive patients on ART in this community may lead them not 
to understand what they are taught by healthcare workers and patients that are unable to 
read would be unable to acquire and understand knowledge from educational material 
distributed by various institutions which promote HIV/AIDS education. 
According to Kozier et al. (2000:466), nurses should assess a patient’s physical, emotional 
and cognitive readiness prior to educating the patient. This will result in effective education. 
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In addition, a threat exists in developing drug resistance and possibly dangerous and fatal 
side effects of ART if patients are not educated about the side-effects, these side-effects 
could cause serious irreparable harm (Zuniga, van Cutsem and Saranchuk, 2010:215). 
Therefore, health education is especially required when treating a patient infected with 
HIV/AIDS as it comprises of many facets that need constant attention. Patients are required 
to have a complete understanding of their disease in order to adhere to treatment and 
contain the disease. Ultimately, this may contribute to an improvement in the quality of life of 
HIV/AIDS infected patients and prevent the spread of the disease. 
1.3  SIGNIFICANCE OF THE STUDY 
The study served to determine the knowledge of HIV positive patients being treated with 
anti-retroviral drugs, regarding HIV/AIDS and ART as well as to determine if there are any 
statistical differences between independent and dependent variables within the study. By 
determining this, insight into the patient’s knowledge of the disease and the patient’s 
management would be gained, including whether this knowledge is influenced by certain 
variables. Scientific evidence obtained in this study would assist policy makers in health 
when developing strategies to improve patient education and compliance.  
1.4 RESEARCH PROBLEM 
In the light of the above, it was identified that problems such as the high influx of patients 
daily as well as an inadequate number of nursing staff in the clinical environment may 
prevent health professionals in providing adequate health education to patients infected with 
HIV/AIDS and receiving ART. Consequently, knowledge of HIV and ART is affected 
negatively and adherence to medication which is closely related to the knowledge of patients 
about the disease and ART is affected.  
1.5 RESEARCH QUESTION 
The question that the researcher explored in this study was: What is the knowledge of 
infected HIV/AIDS patients receiving antiretroviral treatment about HIV/AIDS and 
antiretroviral therapy (ART)? 
1.6 STUDY AIM 
The aim of this study was to determine the knowledge of infected HIV/AIDS patients who are 
receiving ART about HIV/AIDS and anti-retroviral therapy ART  
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1.7 OBJECTIVES OF THE STUDY 
The specific objectives set for this study were to: 
 evaluate the level of knowledge of patients infected with HIV/AIDS about the disease 
 evaluate the level of knowledge of patients infected with HIV/AIDS about ART 
 establish whether there is a statistical differences between the independent and 
dependant variables within the study. 
1.8 RESEARCH METHODOLOGY 
In this chapter a brief overview is described about the methodology applied in the study, a 
more in-depth approach is described in chapter 3.  
1.8.1  Research design 
A quantitative descriptive correlational research design was applied to evaluate the 
knowledge of HIV infected patients receiving ART about the disease HIV/AIDS and ARTs.  
1.8.2  Research Setting  
The study was conducted at the Delft Community Health Centre (CHC) in Delft, Cape Town, 
South Africa, which is a low socio-economic area where there is a high level of poverty, low 
literacy levels, as well as a fairly large HIV population (Statistics South Africa, 2001). Delft 
CHC is a comprehensive primary health care clinic offering a wide range of services to the 
community such as HIV and TB care, chronic disease care, antenatal care, integrated 
management of childhood illnesses as well as family planning, to name a few. Two private 
consultation rooms were provided by the CHC for the conduction of the structured 
interviews.  
1.8.3  Population and sampling 
According to statistics given by the manager of the ARV clinic, the HIV population of Delft 
CHC was 3429 excluding children under 18, of which 2349 patients were on ART. For the 
purpose of this study and in consultation with a statistician and to improve validity, a fairly 
large convenience sample of n= 200 (8.5%) patients was selected from a population of N= 
2349 at the Delft CHC.  
1.8.4  Specific criteria  
Specific criteria set for the purpose of this study for each participant were the following: 
 HIV positive and  receiving ART  
 eighteen years and older  
 either male or female 
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 receiving ART for at least three months 
1.8.5  Data collection tool 
A multiple choice questionnaire (Appendix A) consisting of closed-ended questions with 
multiple responses was developed by the researcher and used for data collection. The 
questionnaire consisted of 20 questions which tested HIV/AIDS and ART knowledge. 14 of 
the 20 questions were critical questions on which the scoring of the patients would be based. 
The questionnaire was in English, but structured interviews took place in, English, Afrikaans 
or Xhosa (with the help of a Xhosa and English speaking fieldworker), depending on the 
participant’s preference.  
1.8.6  Pilot study  
A pilot study was conducted using 10% (n=20) of the sample of the actual study. This was 
done to determine the feasibility of the study and to test the methodology amongst others 
also the questionnaire. The results of the pilot study were not included in the study data.  
1.8.7  Validity and reliability 
Reliability and validity was ensured through the consultation of experts in the fields of 
research methodology, statistics, HIV/AIDS and the Health Research Ethics Committee of 
Stellenbosch University. The questionnaire was revised by various professionals in the field 
and proved to be valid and reliable in the pilot study. The pilot study also added to the overall 
reliability and validity of the study 
 1.8.8  Data collection 
The English and Afrikaans speaking researcher and a trained fieldworker fluent in both 
Xhosa and English conducted structured interviews in two (2) private consultation rooms 
within the Delft CHC. These structured interviews were conducted in the language preferred 
by the participant as the fieldworker and researcher were able to provide in this need. 
1.8.9  Analysis of data 
The researcher had been in consultation with Professor Martin Kidd from the Centre for 
statistical analysis, as well as Dr Justin Harvey, who assisted with the data analysis and 
interpretation. 
All data collected was captured on an excel spreadsheet by the researcher. Thereafter, the 
data was analysed by a statistician using the computerised data analysis programme 
STATISTICA Version 9. For descriptive purposes frequency tables, graphs and means were 
used. For comparison of variables, the types of analyses depended on the types of data 
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compared, but typically included cross tabulation (with the Pearson Chi-square test), 
correlation analyses, t-tests or ANOVA.  
1.9  ETHICAL CONSIDERATIONS 
Permission to conduct this study was requested and granted (Appendix B) from the Health 
Research Ethics Committee of Stellenbosch University, from the Provincial Regional Head 
for Primary Health Care Services (Appendix C), as well as the head of the Delft Community 
Health Centre where the data collection took place. Informed consent was obtained from 
each of the participants in English, Afrikaans or Xhosa depending on the participant’s choice 
(Appendix D, E & F). The participants had a choice whether or not to take part in the study. 
Anonymity was ensured. For this purpose the participants were not required to fill in their 
names, identification or folder numbers anywhere on the questionnaire. 
1.10 LIMITATIONS 
A limitation experienced was that of obtaining permission from the Department of Health 
which was delayed by three months due to internal delays within the department. In addition, 
due to the low socio-economic levels and suspected low literacy rates, structured interviews 
had to be conducted personally with each participant to ensure that they understood what 
was required of a question. The data collection took place over 3 weeks and approximately 
13 participants were interviewed per day. The researcher continued her daily occupation 
during the data collection period and only went to the CHC for a few hours per day during 
this period. The fieldworker also continued her daily work in the CHC, and could not dedicate 
full days to the research. Therefore, the data collection period was much longer than 
expected as each interview took approximately 20 minutes and there was a large sample 
group. 
1.11 CONCEPTUAL FRAMEWORK 
A conceptual theoretical framework explains either graphically, or in the narrative form, the 
main aspects to be studied, the key factors, constructs, or variables and the presumed 
relationships among them (Miles & Huberman, 2003:45).  
According to Mouton (2005:175), conceptual frameworks bring conceptual clarity. A well 
structured conceptual analysis makes conceptual categories clear, explicates theoretical 
linkages and reveals the conceptual implications of different viewpoints. 
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When statements are organised according to certain interests or objectives and become 
integrated into conceptual frameworks, familiar structures of science are found (Mouton, 
2002:195).  
1.11.1 The Innovative Care for Chronic Conditions (ICCC) framework 
In 2003, the WHO developed the ICCC which highlights the need for comprehensive health 
system design or change in order to achieve effective care (Epping-Jordan, Pruitt, Bengoa & 
Wagner, 2004:299). The framework consists of 3 levels including the micro (patient and 
family), meso (healthcare organization and community) and macro (policy) levels. 
The micro level emphasizes that there is a critical role that is played by leaders and 
caregivers in the community (Epping-Jordan et al., 2004:301). It highlights that there is an 
active triad partnership between patients, families, healthcare teams and community 
partners. It is explained that this partnership will function optimally if all members are 
informed, motivated and prepared with skills necessary to manage chronic conditions 
(Epping-Jordan et al., 2004:301).  
The meso level emphasizes the importance of the greater community in playing a supportive 
role to the health care system as well as the patients and families within the community 
(Epping-Jordan et al., 2004:301). The role of the community is to support by ‘bridging the 
gap’ between the health care system and the world of the patients and their families by 
repeating and emphasizing messages about prevention and management of chronic 
conditions (Epping-Jordan et al., 2004:301).  
The macro level stipulates the responsibility of policy-makers and governments to provide a 
positive environment (Epping-Jordan et al., 2004:301).  This can be achieved by providing 
advocacy and leadership, integrating policies, supporting legislative frameworks, promoting 
consistent finances, developing and allocating human resources and strengthening 
partnerships within the community (Epping-Jordan et al., 2004:302). 
In light of the above, it can be seen that health care leaders and providers need to play an 
active role in care amidst the increasing burden of chronic conditions within the communities 
they serve. By equipping health care providers, community members and patients, it is 
envisioned that an effective and positive impact will be made on the community and patients. 
In order to have informed, motivated and prepared health care providers, community 
members and patients, increased provision and time for learning and motivating is crucial 
within the clinical setting. 
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1.11.2 Self-care deficit theory of nursing 
Dorothea Orem’s theory of self-care is based on the philosophy that ‘all patients wish to care 
for themselves’ (Orem, 1971:25). Orem (1991:35) describes self-care as ‘care that is 
performed by oneself when one has reached a state of maturity that is enabling for 
consistent, controlled, effective and purposeful action’. She describes that it is the ‘practice 
of activities that individuals initiate and perform on their own behalf in maintaining life, health 
and wellbeing’ (Orem, 1985:84).  
Taylor (2002:191), defines self-care as ‘the practice of activities that maturing and mature 
persons initiate and perform within time frames, on their own behalf, and in the interest of 
maintaining life and healthful functioning and continuing personal development and well 
being’.  
It is assumed that patients can recover quicker and holistically if they are allowed to perform 
their own self- care. It can therefore also be assumed that patients suffering from HIV/AIDS 
will maintain health if they understand their disease and are able to make informed decisions 
regarding their own self- care. 
Orem (1985:90-100) identified self- care requisites, which are groups of needs or 
requirements for all people. There are 3 categories namely: 
 Universal Self- care requisites: Needs that people have such as; air, water, food, 
elimination, activity and rest, solitude and social interaction, hazard prevention and 
promotion of normality. For the HIV/AIDS patient, as the immune system is 
compromised, good nutrition, regular exercise and preventing exposure to infections 
is essential to maintain health and wellbeing. 
 
 Developmental Self- Care Requisites namely: 
o Maturational: progressing towards a higher level of maturation through 
knowledge and understanding of HIV/AIDS and its treatment. 
o Situational: preventing of negative effects due to development by receiving 
support and acceptance by various people in the community. 
 Health Deviation Requisites: Those needs which arise due to a person’s condition 
which involves seeking medical assistance, medical care and learning to live with the 
disease and complying with prescribed medical regimes, therapeutic and 
rehabilitative measures. Taylor (2002:193) explains that disease does not only affect 
specific physiological or psychological structures, but also integrated human 
functioning and self-care ability.  
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In the case of the HIV/AIDS patient, the patient is required to understand and adhere 
to the treatment regime, knowing what necessary blood tests are needed, what side-
effects may present with ART, what to do in the case of side-effects and how to 
prevent the transmission of HIV/AIDS.  
Orem explains that a self-care deficit occurs when a person is not able to meet their own 
self- care requisites. Here, it is the nurse’s responsibility to identify these deficits and see 
which support modality the patient is grouped into. In the case of an HIV/AIDS patient, 
nurses are to identify deficits knowledge and understanding of HIV/AIDS preventing self- 
care, and to educate appropriately. The three support modalities identified by Orem are: 
 Wholly compensatory: The nurse is expected to accomplish all the patient’s 
therapeutic self- care or when the patient needs continuous guidance in self-care 
(Taylor, 2002:195). If the HIV/AIDS patient has no or little knowledge of his/her 
disease or is very ill, it is the nurse’s responsibility to provide and decide on the 
appropriate and best treatment option for the client. She should also guide and 
educate as much as possible in order for the patient to gain knowledge and 
understanding. This will in turn help the patient to gain the ability to practice self-care. 
 Partly Compensatory: The nurse compensates for self-care limitations and the 
patient performs some self-care measures to meet the self-care needs (Taylor, 
2002:195). When the HIV/AIDS patient has some knowledge regarding his or her 
disease, it is still the nurses responsibility to identify which deficits in self- care there 
are and how to assist the patient, however supporting the patient by educating him at 
all times to reach complete self- care. 
 Supportive- educative: The patient accomplishes self-care and the nurse promotes 
and supports self-care (Taylor, 2002:195). HIV/AIDS patients who have good 
knowledge and understanding, and who are able to practice self- care, must at all 
times be supported as well as encouraged to support and educate other HIV/AIDS 
patients who have not reached self- care. 
Dorothea Orem’s theory on self-care can appropriately be applied to patients suffering from 
HIV/AIDS. As HIV/AIDS is a life threatening and life changing disease, it is important that 
patients are able to regain a feeling of control in their lives. By having informed, motivated 
and prepared nurses continuously educating, supporting and making resources available to 
them, as per the ICCC framework, it will aid patients to regain compliance and ultimately the 
ability of self- care. This relationship between patient’s needs and nurse’s responsibility 
towards the patient is key in attaining the ability for self- care by the patient. The role of the 
nurse in patient education is of absolute importance, as it will be the nurse who will 
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continuously be in the position to identify self-care deficits (Stellenberg, 1995:70).It is 
however ultimately the patient’s choice whether to follow or not follow advice or suggestions 
given by the nurse (Figure 1.1). 
 
 
Figure 1.1: The HIV positive patient’s self- care requisites and the nurse’s responsibility to 
promote self-care, applying to Orem’s self-care theory (illustration by researcher). 
The 
Nurse
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1.12 DEFINITIONS 
Acquired immune deficiency syndrome (AIDS) 
A syndrome involving a defect in cell-mediated immunity that has a long incubation period, 
follows a protracted and debilitating course, is manifested by various opportunistic infections, 
and without treatment has a poor prognosis (Anderson, Keith, Novak & Elliot, 2002:22). 
Antiretroviral therapy (ART) 
The purpose of ART (highly active ART- HAART) is to achieve HIV viral suppression and 
reduce the level of RNA of HIV to as low as possible for as long as possible. It is the 
medication therefore that is effective in delaying the onset of AIDS (Evian, 2008:79).  
Cluster designation four (4) cells 
Cells which are important indicators/ predictors of the risk for acquiring opportunistic 
infections and when to start ART (Evian, 2008:73). 
Human immunodeficiency virus (HIV) 
A retrovirus that causes acquired immunodeficiency syndrome (Anderson, Keith, Novak & 
Elliot, 2002:830). 
Mother–to- child transmission (MTCT) 
Transmission of HIV from a mother to child via pregnancy, childbirth or breastfeeding (Evian, 
2008:223). 
Sexually transmitted infection (STI) 
A contagious infection usually acquired by sexual intercourse or genital contact (Anderson, 
Keith, Novak & Elliot, 2002:1572). 
Tuberculosis (TB) 
A chronic infection caused by an acid-fast bacillus, Mycobacterium tuberculosis. It is usually 
transmitted by inhalation or ingestion of infected droplets and usually affects the lungs, 
although infection of multiple system organs can also occur (Anderson, Keith, Novak & Elliot, 
2002:1761). 
World Health Organization (WHO) 
An intergovernmental organization within the United Nations system whose purpose it is to 
aid in the attainment of the highest possible level of health by all people (Anderson, Keith, 
Novak & Elliot, 2002:1835). 
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1.13 CHAPTER OUTLINE 
Chapter 1: Scientific foundation for the study  
In chapter 1 the background, rationale, significance, research question, goal and objectives 
for the study are described. A brief overview of the research methodology and the 
conceptual framework which guided the study is also described. 
Chapter 2: Literature Review 
In chapter 2 literature regarding HIV/AIDS, the treatment thereof, the importance of patient 
education and gaps in education identified by various studies in the field are discussed. 
Chapter 3: Research Methodology  
In chapter 3 the research methodology as applied in the study is discussed.  
Chapter 4: Data Analysis and Interpretation 
In chapter 4 the results of the study is revealed, analysed, interpreted and discussed.  
Chapter 5: Conclusions and Recommendations 
In chapter 5 the conclusions and recommendations based on the results are described. 
1.14 SUMMARY 
In most of the literature studied, it was observed that the general knowledge level of HIV is 
not what it should be and there are a number of misconceptions regarding HIV/AIDS. 
According to the literature a lack of knowledge and understanding is aiding in non-adherence 
of the patients towards their prescribed treatment regimen which is described in the 
rationale. As HIV/AIDS is constantly changing and new information is regularly published 
about the disease, it is important that patients get regular and ongoing education about their 
disease by informed, motivated and prepared nursing staff. This area was researched in 
order to see what the knowledge level of patients is, where the deficits lie and to make 
recommendations what can be done to improve their level of knowledge and understanding. 
Improving their knowledge and understanding is believed to aid them in becoming 
autonomous, which will lead them to self- care by making informed decisions regarding their 
health, their illness and their treatment. In this chapter the researcher described the 
rationale, as welI as the goals and objectives of the study. A brief description of the research 
methodology applied to the research study was also presented. In the next chapter an in 
depth literature review based on various studies in the field of HIV, patient education and the 
influences of patient literacy are described and a conceptual framework is established on 
which to base the research. 
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CHAPTER 2: LITERATURE REVIEW 
2.1  INTRODUCTION 
In this chapter, the literature review sets out to explore the various aspects of HIV/AIDS, as 
well as the treatment and management thereof. Strategies by various stakeholders, including 
the National Department of Health (DOH), and various studies conducted in this field will be 
explored. According to Burns and Grove (2009:91), the purpose of a literature review is to 
convey what is currently known regarding a specific topic and to obtain a broad background 
and understanding of what is already known about a particular problem and the knowledge 
gaps that exist in the situation. A literature review is a summary of theoretical and empirical 
sources to generate a picture of what is known and not known about the particular area of 
research (Burns & Grove 2007:545). It is conducted to direct the planning and execution of a 
study (Burns & Grove, 2007:137) and provides one with the current theoretical and scientific 
knowledge about the particular problem (Burns & Grove, 2007:135). 
Areas that need to be researched could be gaps that have been identified from previous 
research that has been conducted, but the need arises for it to be conducted in another 
country or institution. Literature was searched for in the Google search engine, medical 
journals, PubMed, the Stellenbosch University Library and other resources available. 
2.2  THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
2.2.1 Historical overview 
HIV is primarily a sexually transmitted disease which was first ‘discovered’ in the United 
States of America in 1981, after a number of homosexual men developed a rarely seen 
pneumonia caused by a bacterium called pneumocystis carinii. These previously well 
homosexual men between the ages of 20 and 45 years had developed a severe immune 
deficiency, which helped this pneumonia to develop. Not long after that, health workers in 
Central Africa, started seeing heterosexual patients representing with a disease called Slims 
disease, which was marked by severe weight loss and diarrhea. The spread of the disease 
was assisted by various means such as; people having unprotected sex and exposure to 
HIV positive body fluids and this is how the disease began to spread throughout the world 
(Evian, 2008:3). Cefrey (2001:24) states that HIV is a virus referred to as acquired, because 
a person has to perform a certain behaviour to become infected by this virus. Many myths 
have been spread about AIDS. There is no cure for HIV/AIDS and while treatment may help 
and some people manage their disease, the condition is still fatal (Jackson, 2002:13). 
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2.2.2 Incidence 
HIV/AIDS is considered a manageable chronic condition (Mukona, Charumbira, Nyamakura, 
Zvinavashe & Manwere, 2011:17), which according to the 2009 AIDS Epidemic Update, 
South Africa constituted 17% of the global HIV/AIDS population and this number is 
continuously increasing. In 2009, 5.7 million people were living with HIV/AIDS in South Africa 
out of 33.4 million people living with HIV/AIDS globally (UNAIDS AIDS Epidemic Update, 
2009:11).  
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), reasons for the 
rapid and continual spread of HIV/AIDS is as result of: 
 Lack of understanding about AIDS and the HIV transmission, 
 Lack of enough counselling 
 Lack of testing services, 
 The effects that stigma and discrimination attached to AIDS has, which often results 
in rejection and violence against people who are HIV positive  
(Pendukeni, 2004:16-17). 
 
2.2.3  Pathophysiology of HIV 
The virus is transmitted through the exchange of fluids during sexual intercourse, blood 
transmission, mother to child transmission (MTCT) as in during pregnancy, birth and breast 
feeding (Evian, 2008:13-17). The impact of HIV on the human immune system depends on 
various factors, including the age of the person, health status and wellbeing, as well as any 
previous diseases or illnesses. Whether or not the person is healthy, the virus will eventually 
affect the person’s immune system so that the function of immune protection is hindered. 
Consequently, it will no longer be able to protect the person from various diseases..  
Rapid multiplication of the HIV virus occurs especially in the first three (3) months (Cefrey, 
2001:8 - 9), known as the window period. The window period is the gap of approximately 
three months between the time when a person becomes infected with HIV and the time 
when antibodies first appear in the blood (Jehuda-Cohen, 2011:179). During this period 
seronegative individuals are an increased threat to others, as they can spread the virus 
although they test negative (Jehuda-Cohen, 2011:179). 
The underlying pathophysiology which results when the HIV virus enters the body, is to 
destroy or cause dysfunction in the helper T cells or CD4 cells, which are known as the 
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immune response cells in the body (Evian, 2008:7). These cells are required to alert the 
immune system to any pathogens which enter the body which may result in a disturbance of 
the normal physiology of the body. These cells are the primary target of the HIV virus. 
Normal CD4 counts range from 700-1000 cells/mm³, but a CD4 count as low as 500 
cell/mm³ could be considered as normal (Wyatt & Sodroski in Smeltzer & Bare, 2004:1553). 
Therefore, the higher the CD4 count the more optimal for the patient.  
2.2.4  The lifecycle of HIV 
The life cycle of the HIV virus consists of a number of stages (Figure 2.1) namely: 
1. Attachment: The HIV virus firstly attaches itself to the CD4 cell receptor  
2. Fusion: The virus then fuses with the CD4 cell wall and the virus then empties its 
content (reverse transcriptase and Deoxyribonucleic acid [DNA]) into the CD4 host 
cell 
3. Reverse transcription: The virus then produces an exact copy of its viral ribonucleic 
acid (RNA) within the host cell to form a double stranded DNA 
4. Integration: The Viral DNA then joins with the host cells’ DNA 
5. Protein production and proteas function: The cell then makes new viral proteins 
within itself which become functional proteins 
6. Maturation: This eventually results in cell replication and starts the whole process 
again 
(Porth in Smeltzer & Bare, 2004:1552). 
This process results in more viruses being produced and more CD4 cells infiltrated and 
destroyed. The patient’s immune response is lowered when HIV destroys the T cells (CD4) 
and consequently patients infected with HIV are more susceptible to infections as the body 
has difficulty defending itself (Evian 2008: 7). 
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Figure 2.1: The Life Cycle of HIV (Illustration by Smeltzer & Bare, 2004:1552). 
2.2.5 Clinical stages 
According to the WHO (2004), there are four clinical stages in this disease which are based 
on clinical criteria. Patients are allocated to a stage based on the clinical symptoms, signs 
and diseases with which they may present, such as pulmonary tuberculosis (TB), a prevalent 
lung disease in South Africa (Harries et al., 2004:32). 
 HIV Stage 1: 
Patients present with either no symptoms or painless swollen lymphnodes (South 
Africa, 2010:27). 
 HIV Stage 2: 
Patients present with symptoms such a recurrent sinusitis, recurrent tonsillitis, mouth 
ulcers, fungal nails infections and unexplained weight loss, to name a few (South 
Africa, 2010:27). 
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 HIV Stage 3: 
Patients are classified to be stage 3 if they have current pulmonary TB or TB within 
the last 12 months, oral thrush, diarrhea for more than 1 month, pneumonia and 
meningitis, to name a few (South Africa, 2010:27). 
 HIV Stage 4:AIDS 
Patients are classified to have AIDS if they fall into stage 4, which is characterised 
with current extrapulmonary TB, herpes simplex of the mouth, Karposi’s sarcoma, 
recurrent severe pneumonia and invasive cervical cancer to name a few (South 
Africa, 2010:27). 
2.2.6  Viral load (VL) and CD4 count 
Regular monitoring of certain blood levels has proven to be very valuable in managing and 
controlling this disease. There are two main blood tests to measure immune status, including 
CD4 count and viral load.  
Viral load ‘explains the measurement of the amount of HIV in the blood expressed which 
assists in monitoring the response to treatment’ (Anderson, Keith, Novak & Elliot,, 
2002:1813), it measures the quantity of HIV RNA in the blood (Smeltzer & Bare, 2004:1548). 
The viral load usually rises to very high levels just after the person has contracted HIV due to 
white blood cells which respond by increasing after identifying the virus in the body (van Dyk, 
2008:50). As soon as the body’s immune system recognizes the virus in the blood, it 
develops an immune response by forming antibodies which then lowers the viral load (Evian, 
2008:27). A higher viral load is inversely proportionate with a low CD4 count. According to 
van Dyk (2008:50) a viral load and CD4 count have a high inverse ‘seesaw’ relationship. A 
viral load is the best indicator of the development speed of the disease. The higher the viral 
load in the blood, the sooner the patient is likely to develop an immune deficiency, and a 
high risk to spread the disease through sexual intercourse, pregnancy or breastfeeding 
(Evian, 2008:27). 
By observing the state of the patient’s immune system, it is easier to predict the patient’s risk 
of developing a symptomatic disease caused by opportunistic infections. The CD4 count is 
thus an important test in monitoring the immune status of the patient (Evian, 2008:26). 
According to the HIV/TB guidelines for the Western Cape (2010:27), prior to starting ART, a 
CD4 count must be done every 6 months, however, the CD4 and viral load count must be 
monitored at 4 months, 12 months and then 12 monthly after commencing ART. This very 
important test is also crucial in monitoring the response of the patient to ARV treatment. 
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2.3  ANTIRETROVIRAL THERAPY (ART) 
According to Ewings, Bhaskaran, McLean, Hawkins, Fisher, Gilson, Nock, Brettle, Johnson, 
Phillips and Porter (2008:90), 50% of people start ART between 2 and 10 years after 
infection. Although not a cure, many HIV positive patients are on ART to assist in decreasing 
the replication of the HIV virus within the body and usually results in near-complete 
suppression of HIV replication (Harries et al., 2004:137). The ultimate goal of ART is to 
prolong life, prevent progression to AIDS, and to improve quality of life for the patient 
(Hammer, Saag, Schechter, Montaner, Schooley & Jacobsen, Thompson, Carpenter, Fischl, 
Gazzard, Gatell, Hirsch, Katzenstein, Richman, Vella, Yeni, and Volberding, 2006:832). 
Determining the stage of the disease is key to routine HIV care, as health workers are then 
able to follow the HIV/AIDS guidelines to decide which treatment option the patient should 
commence with (South Africa, 2010:27-28). 
Unfortunately, there is still no cure for HIV/AIDS, but ART, is the treatment of choice to 
contain the disease. In layman’s terms, ART suppresses the virus and thereby prevents the 
cells to ‘make copies’ or ‘replicate’ themselves (Evian, 2008:79). ART therefore lowers the 
viral load of the HIV in the blood, and by doing so prevents CD4 cells from being destroyed. 
In addition, with the help of ART, the risk of MTCT of HIV is also reduced by reducing the 
mother’s viral load (Zuniga et al., 2010:145). 
According to the Department of Health (2010:6), there are various factors which influence 
the patient’s eligibility for ART.  
2.3.1  Eligibility criteria for ART in South Africa 
According to the new 2010 South African Guidelines, patients are eligible for ART if they 
meet any of the following criteria: 
 A CD4 count ≤ 200cells/mm³ irrespective of clinical stage or 
 A CD4 count ≤350cells/mm³ 
o In HIV positive patients with tuberculosis (TB) 
o In pregnant women or according to 
 WHO stage IV irrespective of CD4 count or 
 Multi drug- resistant (MDR)/ Extensively drug- resistant (XDR) TB irrespective of CD4 
(DOH, 2010:6) 
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2.3.2  ART side-effects 
Most ARV drugs are potentially toxic and may cause side-effects. Most patients tolerate ARV 
drugs well, but the patient and practitioner must always be sensitive for potential 
development of side-effects. Side-effects are usually minor in the first 4-8 weeks of treatment 
but are considered more severe if they develop later (Evian, 2008:88). According to Bhengu, 
Ncama, McInerney, Wantland, Nicholas, Corless, McGibbon, Davis, Nicholas and Ros 
(2011:5), there are many different side-effects which patients experience after commencing 
ART, but not all patients experience the same side-effects.  
Side-effects experienced by patients include: Fatigue, tiredness, skin rashes, headaches, 
insomnia, depression, disturbing dreams and numbness of the feet (Bhengu et al., 2009:5). 
For both the professional nurse in the clinical field and the patient, all side effects of ART are 
important to monitor and to be aware of (South Africa, 2010:32). 
 It is also therefore important that patients know the side-effects of the specific drugs which 
they are on, which side-effects are ‘danger signs’ (i.e. skin rash, jaundice and vomiting) 
(South Africa, 2010:31) and how to react to the side-effect. Depending on the side-effect, 
patients should stop all drugs immediately and consult the nurse practitioner as soon as 
possible (Zuniga et al., 2010:171).  
2.4  DRUG RESISTANCE 
Drug resistance is ‘the ability of disease organisms to resist the effects of drugs that were 
previously toxic to them’ (Anderson, Keith, Novak & Elliot, 2002:553). 
ART is an ongoing, life- long treatment and should be taken as prescribed, every day. If ART 
is not correctly adhered to, the HIV virus is not optimally controlled within the body. As HIV is 
known to rapidly spread by multiplying itself, this uncontrolled virus replicates itself within the 
body in the presence of three (3) ARV drugs and resistance will develop, which is very 
serious (Zuniga et al., 2010:163).  
This condition could lead to the rapid spreading of HIV within the patient causing patients not 
to react or respond to treatment and therefore possibly becoming extremely ill. As there are 
currently only two (2) lines of drug treatment in South Africa, it is important that patients 
adhere to their treatment (DOH, 2010:20), as patients who fail second line therapy have few 
treatment options left available to them (DOH, 2010:20).  
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2.5 ADHERENCE  
Adherence can be defined as, ‘ the process in which a person follows rules, guidelines or 
standards especially as a patient follows a prescription and recommendations for a regimen 
of care’ (Anderson, Keith, Novak & Elliot, 2002:42). 
Adherence to this medication is of cardinal importance, as this is serious there can be 
repercussions due to non-adherence. Incomplete adherence can lead to poor treatment 
outcomes and an increased risk for mortality (Racey, Zhang, Brandson, Fernandes, Tzemis, 
Harrigan, Montaner, Barrios, Toy & Hogg, 2010:816). Therefore, patients’ knowledge of ART 
and their disease is crucial when it comes to treating and managing their disease as 
patients’ understanding and use of health care information can affect their decisions 
regarding treatment (Racey et al., 2010:816).  
Successful management depends on patient understanding and the ability to act on 
treatment information (Wolf, Davis, Arozullah, Penn, Arnold, Sugar & Bennett, 2005:863). 
Adherence to highly active antiretroviral therapy (HAART) medication is the greatest patient 
enabled predictor of treatment success and mortality for those who have access to ART 
(Mills, Nachega, Bangsberg, Singh, Rachlis, Wu, Wilson, Buchan, Gill & Cooper, 
2006:2040). 
2.5.1  Factors influencing adherence 
Adherence is crucial in the treatment and maintenance of the HIV virus. By adhering to 
medication it ultimately prevents the patient from becoming ill and eventually leading to AIDS 
which will ultimately lead to death. According to Bangsberg (2006:939), an adherence rate of 
more than 90% needs to be maintained in order for ART to be effective in achieving and 
maintaining viral suppression. If adherence is not maintained, drug resistance may develop 
which leads to a loss of potentially effective drugs and/or entire drug classes and limits the 
patient’s treatment options (Racey et al., 2010:816-817). 
2.5.1.1 Side effects 
In studies conducted by Rougemont, Stoll, Elia and Ngang (2009:10), it is observed that the 
initial phase or first 6 months of treatment is the most crucial. This is when the patient is ill at 
his/her worst and when ART is initiated, side-effects occur which could make the patient 
despondent, and therefore not adhere to the medical regimen. It was explained that most 
losses to follow-up and death occurred in this initial phase. Studies conducted by 
Guimarães, Rocha, Campos, de Freitas, Gualberto, Teixeira, de Castilho (2008:167) 
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showed that patients’ main reason for finding ART use difficult was because of the severe 
side-effects of the drugs.  
2.5.1.2 Scheduling of appointments 
Scheduling of appointments was sometimes a problem to patients. Many could not take time 
from their jobs to go to the clinic for their appointment, and consequently miss the 
appointments, which could have a negative effect on adherence (Rougemont et al., 
2009:10). 
2.5.1.3 Disclosure 
Disclosure is an important part of ART adherence (Rougemont et al., 2009:10). By disclosing 
the patient’s status to a close person or family member, it places less strain on the patient to 
hide his medication and think of excuses as to why he goes to the clinic often. By disclosing 
the information, the patient allows him/herself to be supported by this person. The person 
can also help then to remember their medication times and support the patient when this is 
necessary. This helps the patient and should have a positive effect on adherence 
(Rougemont et al., 2009:10). Studies conducted by Mills et al. (2006:2056), indicate that fear 
of disclosure was a patient related barrier to adherence to ART. 
2.5.1.4 Substance abuse 
It is said that high alcohol consumption or a co-existing substance addiction decreases 
adherence (Mills et al., 2006:2056). Mills et al. continues to explain that the lack of 
understanding treatment benefits, as well as difficulty understanding treatment instructions is 
a barrier to adherence. Adherence in women seems to be slightly lower than that of men in 
some studies. Women have explained that they sometimes miss their medication due to 
being busy or just simply forgetting (Bhat et al., 2010:948).  
2.5.2 Patient literacy and HIV/AIDS knowledge 
The ability to read and write, which results from formal education, plays an important role in 
HIV/AIDS management as studies indicate that patients with limited literacy skills may lack 
essential knowledge related to HIV/AIDS and treatment (Wolf et al., 2005:863). Limited 
literacy skills affect a person’s ability to use health services effectively, take medications and 
understand additional information related to health (King & Taylor, 2010:24). Weiner 
(2005:57) states that there is a strong relationship between literacy and poverty, and that 
those who have higher reading skills in general, make more money than those who do not. 
Wolf et al. (2005:871), state that there is link between literacy and HIV/AIDS knowledge. The 
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lower the literacy levels are, the poorer the understanding, which results in poorer 
adherence.  
HIV/AIDS has increasingly become an infection of poverty (Smith Fawzi, Jagganathan, 
Cabral, Banares, Salazar, Farmer & Behforouz, 2006:764). Therefore HIV/AIDS progression 
can also be associated with low literacy and low health literacy skills which as identified by 
Neyhart (2008:409) present as barriers to patient education. Health literacy is defined as the 
problem solving and decision making skills that enable a person to apply new information in 
order to navigate their way through the health care system and function successfully as a 
health care consumer (Cutilli, 2007:43). This is one of the strongest predictors of health 
status and well being (Nath, 2007:44). According to Racey et al. (2010:822), higher 
education, employment, income and living in stable housing are all predictors of being able 
to define the development of HIV drug resistance in a community. 
Dewalt, Berkman, Sheridan, Lohr and Pignone (2004:1229), state that patients with low 
literacy skills are generally 1 to 3 times more likely to experience poor health outcomes. In 
studies conducted by Smith Fawzi et al. (2006:770), it was observed that a great lack of 
knowledge regarding HIV transmission was found especially among vulnerable individuals 
affected by combinations of extreme poverty, lack of access to HIV medications and a 
history of abuse. Studies conducted by Wolf et al. (2005:870), revealed that there was a lack 
of understanding of common HIV/AIDS terms such as CD4 count and viral load found in the 
sample of patients with limited literacy skills. It was observed by Racey et al. (2010:816), that 
having higher school education was predictive of HIV/AIDS knowledge such as the ability of 
a person to define the term ‘HIV resistance’.  
Patients need to understand the nature of their treatment, the implication of incomplete 
adherence and the consequences of developing drug resistance (Racey et al., 2010). 
Programmes directed at HIV positive patients coping with poverty and problems need to 
ensure that adequate knowledge is transferred to the patient in order to reduce the overall 
burden of HIV in resource poor communities (Smith Fawzi et al., 2006:770). 
2.5.3  The link between adherence and knowledge of HIV and ART 
In numerous studies conducted, there were some clear misconceptions noted regarding the 
HIV/ AIDS and the treatment of choice which influence adherence levels. In a study 
conducted in Botswana, adherence rates were strongly influenced by misconceptions 
regarding the virus. Out of 400 participants, male and female, 40.3% did not believe that 
they could be re-infected with HIV/ AIDS through sexual intercourse or other means. Kip et 
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al., (2008:152) substantiates that in their study, 9.3% of the participants believe that HIV did 
not really even exist.  
 Another misconception is that some people believe that HIV could be cured by ART. Odu 
and Akanle (2008:86) confirms this by indicating in their study that youth had misconceptions 
that HIV/AIDS could be cured by spiritual, traditional or medical means.  
It was also observed in Soweto, that just below 60% of the participants believe that HIV 
could be transmitted through mosquitoes (Nachega et al., 2005:189). Adequate HIV 
transmission knowledge among HIV positive patients is necessary to reduce the risk of 
secondary infections and to protect the uninfected from transmission (Smith Fawzi et al., 
2006:764). Odu and Akanle (2008:85), found in their study that 62.6% of the participants 
understood that a mother can transmit HIV to her unborn baby. 
In Brazil, Almeida & Vieira (2009:184) showed in their studies that 55% of the HIV positive 
participants on ART did not know how ARV’s worked in suppressing the virus and preventing 
rapid replication. The study also indicates that 36% did not know that they would be taking 
medication for life, and only 14% of the participants knew and gave the correct answer on 
what to do if a dose is skipped. This was also confirmed in studies conducted by Mukona et 
al. (2011:19), which indicated that only 69.4% of the participants understood the functioning 
of ART. 
Nachega et al. (2005:189), showed in Soweto, a relatively high understanding of HIV 
disease progression and transmission, as well as the importance of adherence to 
medication. This could be attributed to the fact that the study took place in a specialized HIV 
treatment clinic within the township, where all patients were HIV positive. Weiser, Wolfe, 
Bangsberg, Thior, Gilbert, Makhema, Kebaabetswe, Dickenson, Mompati, Essex and 
Marlink (2003:283), indicated in their study that participants were well informed regarding 
modes of transmission such as through blood transfusion, sexual intercourse and exchange 
of body fluids. This indicates that there may be a high level of attention given to patient 
education and, making sure that patients understand their disease and treatment, which is 
reassuring. 
Molassiotis et al. (2002:305), revealed the importance and value of regular and ongoing 
patient education, in their study conducted in China. This study showed a 97% ART 
adherence rate. Patients who participated showed good knowledge and understanding 
about medication and related knowledge regarding the importance of adherence in 
preventing drug resistance and how to decrease the risk of drug resistance. These patients 
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had all received regular individual patient education regarding their illness and the 
researchers identified a strong trusting relationship between the patients and the nursing 
staff. 
Patients with inadequate knowledge of HIV/AIDS and transmission are more likely to report 
not taking ART (Smith Fawzi et al., 2006:769).  
2.6 PATIENT EDUCATION 
The above studies show that, by providing regular education by healthcare professionals, to 
patients, the better the understanding the patients have of their disease. Patient education 
can be most meaningful for patients when they are faced with numerous, complex, 
healthcare needs and are expected and required to make challenging and life changing 
choices (Cook, Castrogiovanni, David, Stephenson, Dickson, Smith & Bonney 2008:306). 
According to Racey et al. (2010:822), the goal of patient education is to provide people with 
adequate information about their treatments, in order to ensure optimal treatment outcomes.   
Patient education is a key to disease management, convalescence and overall wellness 
management (Cook et al., 2008:309).  
It is said that patient education can enhance patients’ feelings of confidence and control, 
help build a partnership between the patient and the health care professional. It enables 
patients to participate actively in their own care (Griffin, McKenna & Tooth, 2003:170). 
An important partnership of responsibility is to be developed between the health care 
provider and the patient in order to ensure proper health education (Salmon & Young, 
2005:226). Consideration of education and literacy level is important when educating 
patients, but according to Cook et al. (2008:309), consideration for the afore-mentioned is 
often missed. Patients may adhere to education given to them regarding preventing HIV 
transmission through safe sex practices, taking medication as prescribed and taking 
responsibility for their own health. It is essential that patients completely understand the 
therapeutic plan, as well as the potential consequences deriving from it (Racey et al., 
2010:822), as lack of knowledge has a strong link to adherence (Wolf et al., 2005:864) and 
low adherence with increased risk for drug resistance and therefore mortality (Racey et al., 
2010:816). 
Knowledge and understanding of HIV/AIDS will in turn reduce the amount of HIV cases in 
the community, in the country and eventually globally. However, serious misconceptions 
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may also exist in communities about HIV/AIDS as described above which may influence 
adherence to medication. 
2.6.1  Factors preventing effective patient education 
According to Kozier et al. (2000:461), emotions, prognosis, language and culture are factors 
inhibiting patients from learning. Emotions such as fear, anger, depression and anxiety result 
in an inability for the patients to concentrate and focus on what they are being educated 
about. If patients are preoccupied by their prognosis, they will not concentrate on the 
information being conveyed to them. Neyhart (2008:409) suggests that information overload 
can prevent effective patient education, as well as language barriers. This is aggravated by 
medical language which can be challenging for people with low literacy levels (King & Taylor, 
2010:28). If the patient does not understand what is being said due to a language barrier, the 
education given will also be unprofitable. Cultural barriers may have an important effect on 
learning (Neyhart, 2008:409). Values of Western culture could conflict with the cultural 
values of the patients and lead to poor adherence to advice and treatment offered or 
recommended. 
Furthermore, overcrowded clinics aggravate the management of patients daily. The high 
influx of patients into clinics every day increases time compression, which minimizes 
consultation time and thereby diminishes the opportunity for effective patient education 
regarding HIV/AIDS (Neyhart, 2008:409). Possible illiteracy (Neyhart, 2008:409), of HIV 
positive patients on ART in low socio-economic areas may lead patients not to understand 
what they are taught by healthcare workers. In addition patients who are unable to read will 
be unable to acquire knowledge from education material distributed by various institutions 
which promote HIV/AIDS counselling and education. 
2.6.2  Factors promoting effective patient education 
Most health information patients receive is through patient education (King & Taylor, 
2010:24). Counselling is the process that helps people understand and deal with their 
problems as well as communicate better with those whom they are emotionally involved with 
(Evian, 2008:279). Counselling does not involve just giving advice or taking over the 
patient’s problem. Counselling is when one encourages the patient to find his/her own 
solutions to problems, helping him/her thus to become an independent and confident person 
(Evian, 2008:279). The deficit in available time for patient education could play a major role 
in the self–care and autonomy of the patient. A patient who is autonomous can make 
informed decisions based on knowledge and experience. 
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According to Kozier et al. (2000:466), nurses should assess a patient’s physical, emotional 
and cognitive readiness prior to educating the patient. Clinicians can assess literacy skills 
prior to HAART enrolment and provide additional information and support (Wolf et al., 
2005:871).This may result in effective education. In addition, a threat exists in developing 
drug resistance and possibly dangerous and fatal side-effects of ART. If patients are not 
educated about the side- effects they need to be aware of, these side-effects could cause 
serious irreparable harm. 
Therefore, health education is especially required when treating a patient infected with 
HIV/AIDS as it comprises many facets that need constant attention. Patients are required to 
have a complete understanding of their disease in order to adhere to treatment and contain 
the disease. Ultimately this may contribute to an improvement in the quality of life of 
HIV/AIDS infected patients and prevent the spread of the disease. Knowledge of ART and 
HIV/AIDS will empower the HIV positive individual. The individual will consequently be 
motivated to be part of the collaborative process because initiation of ART is a clinical 
decision, which should always be made jointly between the informed patient and the 
healthcare provider (Mukona et al., 2011:19). 
By educating HIV positive people in such a way that it leads to full understanding of their 
disease and treatment thereof, it is believed that this will lead to patients being able to take 
control of their own self-care and assist in making informed decisions based on what they 
know, understand and have been educated on (Cook et al., 2008:309). Epping-Jordan, 
Pruitt, Bengoa and Wagner (2004:299) state that creative ideas and solutions are needed to 
address the increasing healthcare demands of chronic conditions, especially in countries 
with limited or stressed primary healthcare infrastructure. 
2.7 SUMMARY 
HIV/AIDS is a serious disease and the incidence is increasing daily. According to the 
literature discussed, it is a complex disease which needs to be understood by patients in 
order for proper management to be conducted as the patient has a high risk of spreading the 
HIV virus to other people as well as compromising their own health status should they not 
adhere to treatment.  
As reported in this chapter, studies show that there are few HIV positive people who show 
full understanding of HIV, due to various factors. Those, however, who have adequate 
adherence to and knowledge of the management of HIV/AIDS, have shown to flow from 
good patient education by medical staff as well as regular follow-up, which has led to more 
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effective treatment and prevention. Patient education plays an essential role in the 
management of patients, as regular and ongoing education promotes knowledge and 
understanding which lead to patients successfully making informed decisions and good 
choices regarding their self-care and health. 
An overview of the objectives of this study was thus provided by investigating the literature. 
This study further investigated whether similar problems or situations were present in the 
Delft community and the results thereof are discussed in chapters 4 and 5. 
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CHAPTER 3: RESEARCH METHODOLOGY 
3.1 INTRODUCTION 
Chapter 3 outlines the research methodology being applied during this study. Included in this 
chapter is a discussion of the research design, the research problem, the study population, 
the sampling procedure, data collection methods, data analysis and limitations of the study. 
3.2  RESEARCH DESIGN 
A descriptive quantitative correlation research design was applied to obtain important 
information of HIV positive patients on ART. A descriptive correlation design describes 
variables and examines relationships among these variables. This design facilitates the 
identification of interrelationships in a situation (Burns & Grove, 2007:249). According to 
Mouton (2005:55), a research design is a plan or a blueprint of how one conducts the 
research. A research design ensures that research is conducted in a logical and organized 
manner in order to ensure reliability and integrity. Polit and Beck (2008:765), confirm this by 
stating that a research design is the overall plan for addressing a research question, 
including specifications for enhancing the study’s integrity. Quantitative research is a formal, 
objective and systematic process used to describe variables, test relationships between 
them and examine cause-and-effect interactions among variables (Burns & Grove, 
2007:551). Brink and Wood (2001:83), explain that a variable is anything that varies, or any 
property that takes on different values. These can be characteristics of people, things or 
situations which can change or vary and they are manipulated or measured in research 
(Burns & Grove, 2007:559). The aim of this study was to evaluate HIV positive patients’ 
knowledge of HIV/AIDS and the treatment thereof. 
3.3 POPULATION AND SAMPLING 
3.3.1  Population 
A study population can be described as the entire set of individuals or objects having some 
of the same characteristics (Polit & Beck, 2008:761). Burns and Grove (2007:549), explain 
that a population is all the elements that meet the sample criteria for inclusion in a study, 
sometimes referred to as the target population. The specific target population for this study 
included all HIV positive patients on ART above the age of 18 at the Delft Community Health 
Centre. The total number of patients who met the specific criteria for this study was 
(N=2349).  
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3.3.2  Sampling 
Sampling is described by Loiselle, Profetto-McGrath, Polit and Beck (2010:208), as the 
process of selecting a portion of the population to represent the entire population. It is the 
subset of the population and is made up of elements which are usually humans (Loiselle et 
al., 2010:208). It involves selecting a group of people, events, behaviours, or other elements 
with which to conduct a study (Burns & Grove, 2007:324). In this study a convenience 
sampling method was used. Convenience sampling is also known as ‘accidental sampling’, 
as the subjects are included in the study because they happen to be at the right place at the 
right time (Burns & Grove, 2007:337). For the purpose of this study, guided by a statistician, 
a convenience sample of n=200 (8.5%) patients was selected from the Delft CHC. It was 
decided that the first 200 patients who voluntarily gave consent to participate in the study 
would be included in the sample to improve the validity of the study. A large sample adds to 
the validity of the study. Convenience sampling was best suited for this study due to the 
profile of the patients attending this clinic. The clinic is situated in a low socio-economic 
environment within which poverty and low literacy levels dominate. Therefore, various 
factors influence the regular attendance of patients to the clinics such as the availability of 
transport, unemployment and finances.  
3.3.3  Criteria 
The following criteria were set for this study: 
Specific Criteria 
All HIV positive male or female patients above the age of eighteen who have been on ART 
for at least three months attending Delft CHC, qualified to take part in this study. 
3.4 RESEARCH SETTING 
The study was conducted at the Delft CHC, which is situated in a low socio-economic area 
characterized by high levels of poverty and low literacy levels (Statistics South Africa, 2001), 
as well as a fairly large HIV population. Delft CHC is a comprehensive primary health care 
clinic offering a wide range of services to the community such as HIV and TB care, chronic 
disease care, antenatal care, integrated management of childhood illnesses as well as family 
planning, to name a few. Two private consultation rooms were provided by the CHC in order 
for structured interviews to take place. 
3.5  PILOT STUDY 
A pilot study was conducted to test the feasibility of the study, as well as the validity and 
reliability of the data collection tool. It was conducted in order to ensure that aspects, such 
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as the correct methodology and data collection procedure were followed, including reviewing 
the questionnaire for any errors. Burns and Grove (2007:28), explain that a pilot study is 
frequently defined as a smaller version of the proposed study, and it is conducted to refine 
that study. Mouton (2005:103) explains that failure to conduct a pilot study, is one of the 
most common errors which researchers make. The sample for the pilot study in this study 
was (n =20/10%) of the actual number of participants proposed for the sample of the main 
study. The pilot study was also conducted at Delft CHC. All participants from the pilot study 
were excluded from the actual study. All participants responded well to the questionnaire by 
answering honestly and giving of their time, and only a minor adjustment was made to the 
questionnaire afterwards, i.e. including the answer ‘I don’t know’ for the multiple choice 
questions for the main study, as some participants were unable to make a choice from the 
multiple choice answers provided.  
3.6  RELIABILITY AND VALIDITY 
Reliability refers to the consistency of the measures obtained in the use of a particular 
instrument and indicates the extent of random error in the measurement method (Burns & 
Grove, 2009:377). Consistency is an ideal strived for by every researcher, as this ensures 
that the research outcomes are accurate (Neuman, 2006:188). The reliability of a 
measurement procedure is the stability of the measurement. It can be increased by clearly 
conceptualising constructs, using a pilot study and using multiple indicators of a variable (De 
Vos, Strydom, Fouche & Delport, 2007:163). According to Brink (2006:163) reliability is the 
degree to which the instrument could be depended upon to yield consistent results, 
specifically if it is used repeatedly over time by the same person, or another researcher. To 
ensure reliability and validity, a pilot study was conducted to test the instrument, as well as 
the feasibility of the study. Rubin and Babbie (2011:195) state however, that reliability does 
not ensure accuracy, as bias may also occur. Therefore, attempts to reduce bias were made 
by the researcher by allowing voluntary participation by the study participants in a private 
room. 
Validity of an instrument determines the extent to which it actually reflects the abstract 
construct being examined (Burns & Grove, 2009:381) and face validity verifies that the 
instrument looked like it was valid and gave the appearance of measuring what it is 
supposed to measure (Burns & Grove, 2009:381). A pilot study was conducted in order to 
test for face validity and the instrument presented as a professional typed document which 
was simple to complete.  
Stellenbosch University http://scholar.sun.ac.za
 33 
 
Validity will vary from one sample to another and from one situation to another; therefore 
validity testing evaluates the use of the instrument for a specific group or purpose rather, 
than the instrument itself (Burns & Grove, 2007:365). Content validity examines the extent to 
which the measurement tool includes all the major elements relevant to the construct being 
measured (Burns & Grove, 2009:381). The questionnaire was designed after an extensive 
literature review was conducted on various aspects of the subject. The content validity was 
validated by the study supervisor, an expert in the field of research methodology and 
nursing, as well as by three (3) other experts in the fields of nursing, HIV and research. The 
questionnaire was then also reviewed by an expert in statistics to ensure the suitability of the 
questionnaire for data analysis. The questionnaire proved to be reliable and valid through 
the pilot study. 
3.7  INSTRUMENTATION 
Instrumentation of this study was applied by means of a questionnaire (Appendix A). A 
questionnaire is a printed, self report form, designed to elicit information through written 
verbal responses of the subject (Burns & Grove, 2007:382). Questionnaires are used to 
gather a broad spectrum of information from subjects. These include demographic facts 
about the subject, as well as information regarding beliefs, attitudes or knowledge (Burns & 
Grove, 2007:382). The questionnaire may consist of open-ended questions, which requires 
written responses from the subject or closed-ended questions, which only have answers 
selected by the researcher (Burns & Grove, 2007:382).  
In this study, a questionnaire with 26 multiple choice questions and 3 closed-ended 
questions was designed by the researcher. The questionnaire was used and completed by 
the researcher and fieldworker during individual structured interviews. The researcher 
trained the fieldworker by means of allowing her to sit in 5 interviews which the researcher 
conducted, so that she was able to observe how questions were to be asked. The 
fieldworker then conducted 2 individual interviews in the presence of the researcher before 
she was allowed to conduct interviews on her own. 
There were 20 questions which tested knowledge of HIV/AIDS and ART of which 14 of the 
questions were marked as ‘critical questions’, as these were the basic questions that all HIV 
positive patients should know. Participants were scored according to the number of correct 
answers to the critical questions. Participants were considered as good if they had all 14 
critical questions correct, average if they had 11-13 correct and poor if they had 10 or less 
correct. The advantage of a questionnaire is that it offers the possibility of complete 
anonymity, which is crucial in obtaining truthful responses and it prevents interviewer bias, 
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since there is an absence of an interviewer (Polit & Beck, 2008:424). In the case of the 
questionnaire used in this research, interviewer bias was prevented by allowing the 
researcher or fieldworker only to read a question and read out the set answers in the 
questionnaire. The instrument was also ethically approved by the Health Research Ethics 
Committee. The questionnaire designed consisted of two sections, i.e. A and B. 
Section A comprised of demographic data such as: 
 Age 
 Gender 
 Home language 
 Highest level of education achieved 
 Ability to read and write 
 Period living with HIV 
 Period receiving treatment. 
Section B covered an overall testing of knowledge regarding HIV/AIDS and ART, as well as 
an indication of where each participant learnt most of his/her knowledge about the subject.  
These include: 
 Mechanism of action of the HIV virus 
 Transfer of HIV 
 Meanings of various terms and the importance of testing them, such as ‘window 
period’, ‘CD4 count’ and ‘viral load’  
 Knowledge of ART, side effects, dosages and stopping medication. 
Multiple choice questions were used as it allowed the researcher and fieldworker to read out 
the question and the choice of answers to each participant. This ensured minimal influence 
by the interviewer and assisted the participant by limiting the amount of answers that they 
could choose from.  
3.8  DATA COLLECTION 
Data collection is the process of acquiring the subjects and collecting the data for the study 
(Burns & Grove, 2007:391). The data for this study was collected over a period of three (3) 
weeks by means of structured interviews by the researcher and fieldworker, with the use of 
the questionnaire in private consultation rooms. Each participant had their own 
questionnaire; therefore 200 questionnaires were printed for individual structured interviews. 
During the interview, each participant was provided with an information leaflet explaining the 
purpose of the study as well as an informed consent form which was available in English, 
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Afrikaans and Xhosa (Appendix E, F & G). Once consent was obtained, the researcher (in 
English or Afrikaans) or fieldworker (in English or Xhosa) conducted the interview by reading 
questions in a language which the participant understood, as well as providing all possible 
answers from the questionnaire (Appendix A) from where the participant could select 
answers. Thereafter, the answer chosen by the participant was clearly marked with a tick on 
the questionnaire by the interviewer. Questionnaires were kept by the researcher or 
fieldworker at all times and participants were not able to see the questionnaire. The duration 
of each structured interview was 20-25 minutes in total. Participants were selected according 
to availability and the willingness of each participant present at the ART clinic on the 
particular day and who complied with the specific criteria set for the study. If a participant 
declined, the next person was approached. A total of (n=200/8.5%) of the population 
(N=2349) formed the sample. Only 2 people declined to take part in the study due to time 
restraint. 
3.9  DATA ANALYSIS AND INTERPRETATION  
Data analysis is conducted to reduce, organize and give meaning to data (Burns & Grove, 
2009:695). It involves breaking up the data into manageable themes, patterns, trends and 
relationships (Mouton, 2005:108). Accuracy is very important when capturing the data on the 
computer as it can threaten the validity of measures and cause misleading results (Neuman, 
2006:346). The aim of analysis is to understand the various constitutive elements of one’s 
data through an inspection of the relationships between concepts, constructs or variables 
and to see whether there are any patterns or trends that can be identified or isolated 
(Mouton, 2005:108). Statistics are often used not only to describe some characteristics of a 
sample group, but also to test for similarities, or differences between groups (de Vos et al., 
2007:218). 
After each interview, the completed questionnaires were placed in a file as well as informed 
consent forms were placed in a separate file. Questionnaires and informed consent forms 
were collected from Delft CHC on a daily basis by the researcher.  
The data from each questionnaire was captured by the researcher on an excel spreadsheet. 
The researcher had been in consultation with two statisticians from the Centre for statistical 
analysis. The excel spreadsheet was then sent to one of the statisticians who assisted with 
the data analysis and interpretation. For descriptive purposes frequency tables, histograms, 
means and standard deviations were used. For comparison of variables, the types of 
analyses depended on the types of data compared, but typically included cross tabulation 
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(with the Chi-square test), correlation analyses or ANOVA. Descriptions of each term and 
test follow which was applied in the study and presented in chapter 4. 
3.9.1 Scoring system 
As discussed in paragraph 3.6, the questionnaire consisted of a total of 29 questions of 
which 20 tested HIV/AIDS and ART knowledge. Certain questions in the questionnaire were 
identified as critical questions and it was expected that participants would be able to answer 
these questions whereas the others were seen as ‘good to know’. In consultation with 
various professionals in the field of HIV/AIDS, 14 critical questions were identified to be the 
basis for deciding whether or not the participants in the study had good, average or poor 
knowledge of HIV/AIDS and ART. 
The scoring is as follows: 
 Good knowledge: The participant has all 14 critical questions correct 
 Average knowledge: The participant has 11-13 critical questions correct 
 Poor knowledge: The participant has 10 or less critical questions correct. 
3.9.2  Mean 
The mean is the value obtained by summing up all the scores and dividing the total by the 
number of scores being summed (Burns & Grove, 2009:708). 
3.9.3  Median 
The median is the score at the exact centre of the ungrouped frequency distribution (Burns & 
Grove, 2007:546). According to Burns and Grove (2009:472), it is the most appropriate 
measure of central tendency for ordinal data but is also used for interval and ratio data. 
3.9.4  Standard Deviation 
Standard deviation is a measure of dispersion that is the square root of the variance (Burns 
& Grove, 2009:474). 
3.9.5  Pearson Chi-square 
According to Polit and Beck (2008:749), the chi-square test is a statistical test, which 
assesses the difference in proportions and Polit and Beck (2008:749) describe the chi-
square test, symbolized by X², as a statistical test, used to assess differences in proportions. 
3.9.6  Analysis of Variance (ANOVA) 
A statistical test used to examine differences among two or more groups by comparing the 
variability between groups with the variability within each group (Burns & Grove, 2007:530). 
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3.9.7  Fisher’s Exact Test 
A statistical test used to determine if there are nonrandom associations between two 
categorical variables (Weisstein, 2011).  
3.9.8  T-test 
A parametric analysis technique used to determine significant differences between 
measures of two samples (Burns & Grove, 2007:558). 
3.10 ETHICAL CONSIDERATIONS 
According to Terre Blanche and Durrheim (2004:65), ethics is defined as the study of moral 
standards. It is the branch of philosophy that deals with morality (Burns & Grove, 2009:61). 
As research in nursing not only requires expertise and diligence but also honesty and 
integrity (Burns & Grove, 2009:184), conduct and research designs should always reflect 
careful attention to the ethical issues embodied in research projects. Ethical issues must be 
considered when presenting research sources. The content from other studies must always 
be presented honestly and not be distorted (Burns & Grove, 2007:156). Three principles 
have been identified with which to approach ethical issues in research. These include 
autonomy, non-maleficence and beneficence. 
i. Autonomy 
The principle of autonomy states that people should be allowed to be self-governing 
and make decisions for themselves (Kerridge, Lowe & McPhee, 2007: 46). All 
participants participated voluntarily during this study and it was explained to each 
participant that they could discontinue their participation at any time should they feel 
to do so. 
ii. Non-maleficence 
Non-maleficence can be defined as ‘above all, do no harm’ (Kerridge et al., 2007: 
46). This principle is also important with regards to the way data is stored and who 
will have access to the data (Watson, McKenna, Cowman & Keady, 2008:131). All 
participants were assured that only the researcher, fieldworker and supervisor would 
have access to the data they provided. 
iii. Beneficence 
The principle of beneficence may be described as active well-doing, altruism or 
conduct aimed at the good and well-being of others (Kerridge et al., 2007: 46). All 
participants were handled in an honest and open way, which allowed for them to ask 
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as many questions as they desired in order to have obtained clarity on what was 
needed of them for the research. 
In addition, principles of justice and confidentiality were adhered to at all times. All 
participants were treated equally in a fair and just manner. All information given by the 
participants was available only to the researcher and fieldworker. Information was reported  
in such a manner that responses could not be linked to the identities of the participants. 
3.10.1 Permission to conduct the study 
Permission to conduct this study was obtained in writing from the Health Research Ethics 
Committee of Stellenbosch University on 8 April 2011 (Appendix B) and from the Provincial 
Regional Head for Primary Health Care Services on 8 August 2011 (Appendix C). Verbal 
permission was obtained on 9 August 2011 from the head of the Delft Community Health 
Centre where the data collection took place. Written informed consent was obtained from 
each of the participants, where a form (Appendix D, E & F) was available in English, 
Afrikaans or Xhosa depending on the participant’s choice. The participants had a choice 
whether or not to take part in the study. Anonymity was ensured at all times. For this 
purpose the participants were not required to fill in their names, identification or folder 
numbers anywhere on any of the data forms. 
3.11 LIMITATIONS 
There were two (2) main limitations identified during the course of the study namely: 
 Obtaining permission from the Department of Health was delayed by 3 months which 
prevented the researcher from beginning with data collection, despite having 
obtained ethical approval by the Health Research Ethics Committee of Stellenbosch 
University. 
 As the questionnaire was only available in English, a possibility of bias may have 
been present due to the translation process during each individual structured 
interview despite efforts by the researcher and fieldworker to prevent this. 
3.12 SUMMARY 
A descriptive, quantitative correlation research design was applied to this study on a 
population of (N=2349). A sample size of (n=200/8.5%) was selected from Delft Community 
Health Centre ART clinic by means of convenience sampling. The criteria for the study 
included any HIV positive male or female, above the age of eighteen, who had been on ART 
for more than three (3) months. A pilot study was conducted with (n=20/10%) of the sample 
(n=200) participants of the main study. The instrument was thereafter analysed and a few 
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small alterations were made to the questionnaire. The questionnaire consisted of 26 multiple 
choice questions and 3 closed-ended questions. The information covered on the 
questionnaire ranged from the participant’s demographic data to knowledge of HIV/AIDS and 
ART. The data was then collected over a period of three weeks by means of structured 
private interviews by the researcher or trained Xhosa fieldworker with each participant, which 
lasted approximately 20-25 minutes each. Each participant was required to give written 
consent should they be willing to participate in the study. Thereafter, interviews were 
conducted with each participant by asking them questions on the questionnaire and 
providing the answers from which to choose in a language of their choice. With the help of a 
statistician, the data was analysed and interpreted by the researcher. Ethical principles of 
autonomy, non-maleficance, beneficence, justice and confidentiality were at all times 
considered and applied. Written permission to conduct the study was obtained from the 
Health Research Ethics Committee of Stellenbosch University, as well as from the Provincial 
Regional Head for Primary Healthcare Services. The data analysis, interpretation of the data 
and related discussions of the results are presented in chapter 4 
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CHAPTER 4: PRESENTATION, ANALYSIS AND 
INTERPRETATION OF RESULTS 
4.1 INTRODUCTION 
In this chapter, the analysed results from this study are interpreted, discussed and presented 
in tables and graphs. Results are predominantly quantitative in nature and will be 
presented by means of figures and tables. Numbers and percentages were used to 
simplify interpretation and understanding.  
4.2 STATISTICAL ANALYSIS 
The data was analysed with the help of a statistician, using the computerised data analysis 
programme, STATISTICA Version 9. The p-value is the measure which is reported from all 
tests of statistical significance. This value shows the probability that one variable is 
dependent on another or if an effect will happen by chance. In medical research, various 
statisticians and researchers have agreed that if the p-value is more than 5% (p> 0.05) there 
was an insignificant difference between the variables tested. If the p-value is less that 5% 
(p≤ 0.05), there is a statistically significant difference between variables (Attia, 2005:78). In 
medical research a 95% confidence is usually used (Attia, 2005:79), therefore, a 95% 
confidence interval with a significance level of (p≤0.05) was used to establish statistically 
significant associations between variables as discussed. The data is presented completely in 
a quantitative form.  
A full description of the tests used during the data analysis was discussed in section 3.8 of 
chapter 3. 
The discussion of the results and interpretation of all the variables covered in the 
questionnaire follows hereafter. 
4.3 SECTION A (DEMOGRAPHIC DATA) 
4.3.1 Age 
The response rate to this question was (n=200/100%) with a mean age of 37.5 and a 
median age of 36.5. The minimum age was 19 years and the maximum age was 62 years 
(Figure 4.1). 
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Figure 4.1: Age range, mean, median and age of participants 
4.3.2 Gender 
According to the data, (n=145/72.5%), the majority of the participants were female (Table 
4.1). These results are supported by the 2007 AIDS Epidemic Update (2007:8), which 
indicates that more women are living with HIV/AIDS than men. In 2007, 61% of the 
HIV/AIDS population in Sub-Saharan Africa were women. It is also stated in the Second 
National HIV Communication Survey 2009 - findings from the Western Cape (2009:8), that 
men are more likely to have multiple sex partners as opposed to women. This may result in 
multiple women being infected by one male.  
Table 4.1: Gender 
Gender n(%) 
Female 145(72.5) 
Male 55(27.5) 
TOTAL 200(100) 
4.3.3 Home Language 
The dominant language spoken by the participants was Xhosa (n=150/75%), followed by 
Afrikaans (n=36/18%) and English (n=7/3.5%) (Figure 4.2). These results are aligned with 
the Western Cape Provincial Languages Act, which states that these three languages are 
the official languages of the Western Cape (South Africa, 1998:3). 
Stellenbosch University http://scholar.sun.ac.za
 42 
 
 
Figure 4.2: Distribution of home language 
4.3.4 Highest Level of Education 
Racey et al. (2010:816) state that higher education is predictive of HIV/AIDS knowledge. 
According to Africa, Budlender and Mpetsheni (2001:14), it was found that 22% of people in 
South Africa above the age of 26 years had no formal schooling or education. In this study 
however, results show more than 50% (n=112/56%) of the participants in Delft had an 
education level higher than grade 9 (Figure 4.3) and that (n=48/24%) of the participants had 
achieved grade 12. It was also found that only (n=41/20.5%) had a primary school 
achievement and only (n=2/1%) had no schooling at all. This is also an improvement of the 
statistics given by the census in 1996 which stated that 6% of all people between 16 and 26 
years had no formal schooling (Africa et al., 2001:1).  
 
Figure 4.3: Distribution of Education Levels 
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4.3.5 Literacy Level 
According to Neyhart (2008:409), low literacy and low health literacy skills present frequent 
barriers to patient education. The data revealed that (n=196/98%) of the participants were 
literate and that only (n=3/1.5%) of the participants were completely illiterate, they could not 
read or write (Table 4.2). According to Wolf et al. (2005:863), the ability to read and write, 
which results from formal education, plays an important role in HIV/AIDS management as 
studies indicate that patients with limited literacy skills may lack essential knowledge related 
to HIV/AIDS and treatment. Nath (2007:44) confirms this by stating that health literacy is one 
of the strongest predictors of health status and well being. 
Table 4.2: Literacy levels 
Literacy level n(%) 
Cannot read or write 3(1.5) 
Can read only 1(0.5) 
Can read and write 196(98) 
TOTAL 200(100) 
4.3.6 Length of Time Living with HIV/AIDS 
The data revealed that (n=15/7.5%) of the participants had been living with HIV/AIDS for 
less than one year while (n=73/36.5%) had been living with HIV/AIDS for more than five (5) 
years (Table 4.3).  
Table 4.3: Length of time living with HIV 
Length of Time n(%) 
<1 year 15(7.5) 
1-3 years 60(30) 
3-5 years 51(25.5) 
>5 years 73(36.5) 
Don’t know 1(0.5) 
TOTAL 200(100) 
4.3.7 Length of Time on Antiretroviral Therapy 
The data revealed that (n=78/39%) of the participants had been on treatment for 1-3 years 
(Figure 4.4) and that only (n=35/17.5%) had been on treatment for more than five (5) years. 
However, as described in paragraph 4.3.6 the majority of participants (n=73/36.6) indicated 
that they have been living with HIV for more than five (5) years. It can therefore be 
concluded that most people lived with HIV/AIDS for approximately two (2) years or more 
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before starting treatment. This is confirmed by Ewings et al. (2008:90), who stated that 50% 
of HIV positive people start ART between 2 and 10 years after infection. 
 
Figure 4.4: Distribution of participants’ years on ART 
4.4 SECTION B (KNOWLEDGE OF HIV/AIDS AND ART) 
4.4.1 What does the HIV virus do in the body? 
The results showed that only (n=114/57%) correctly indicated, ‘kills the immune system’ 
(Table 4.4). This is basic information regarding HIV/AIDS, and patients suffering from 
HIV/AIDS should have a basic understanding of the pathophysiology. According to literature, 
irrespective of the individual’s health status, the HIV virus does eventually affect the person’s 
immune system to such an extent that the immune function is hindered, resulting in the 
person becoming more susceptible to various diseases (Cefrey, 2001:8-9). This was a 
critical question. 
Table 4.4: What does HIV do in the body? 
What does HIV do in the Body? n(%) 
Kills the immune system 114(57) 
Destroys your organs 57(28.5) 
Causes TB 16(8) 
Makes you stronger 2(1) 
I don’t know 11(5.5) 
TOTAL 200(100) 
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4.4.2 Is HIV spread through any of the following? 
Kissing 
The HIV virus is transmitted through the exchange of fluids during sexual intercourse, blood 
transmission, MTCT during pregnancy, birth and breast feeding (Evian, 2008:13-17). 
The results showed that (n=193/96.5%) of the participants indicated that HIV is not spread 
through kissing (Table 4.5). The results further indicated that there was a significant 
statistical association between literacy level and whether kissing could spread HIV (Pearson 
Chi-square, df=2, p = 0.02). The higher the education levels the more likely the correct 
answer was given. Furthermore, a statistical association was also found between the years 
on antiretroviral therapy and whether kissing spread HIV (Figure 4.5). The longer the 
participants were receiving ART therapy the more likely they would give the correct answer 
(Pearson Chi-square, df=2, p=0.02). This was a critical question. 
 
Figure 4.5: Distribution of answers for whether kissing can spread HIV correlated with number 
of years on ART 
Hugging 
Data analysis indicated that (n=198/99%) of the participants confirmed that HIV could not be 
spread through hugging (Table 4.5). A significant association between education and 
hugging was found (Pearson Chi-square, df=12, p≤0.01). T-tests for independent groups 
found that the mean age of those participants who incorrectly answered ‘yes’ was 50.5 years 
and those that correctly stated ‘no’ was 37.4 years which is statistically significant (p=0.04).  
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Sexual intercourse 
The analysis indicated (n=198/99%) of the participants chose the correct answer that sexual 
intercourse can spread HIV (Table 4.5), which corresponds with the study conducted by Odu 
and Akanle (2008:85), where 98.8% of the participants indicated that HIV could be spread 
through sexual intercourse.  
Wesier et al. (2003:283), substantiates the results of this study who also found that 98% of 
their participants indicated that HIV could be spread through sexual intercourse. Although 
statistically insignificant, T-tests for independent groups found that the mean age of those 
participants who correctly stated ‘yes’ was 37.5 years and those who incorrectly stated ‘no’ 
was 47 years. Further analysis showed that there was also a significant statistical 
relationship between educational level and whether or not sexual intercourse could spread 
HIV (Pearson Chi-square, df=12, p=0.01). 
Mosquitoes 
The results showed that (n=180/90%) of participants correctly indicated that mosquitoes do 
not spread HIV and that only (n=20/10%) indicated that they do spread HIV (Table 4.5). In 
contrast, these results do not compare to the study conducted by Nachega et al. (2005:189) 
in Soweto, in which 60% of the participants in the study indicated that HIV could be spread 
by mosquitoes. 
There was also a statistically significant association found between education level and 
whether HIV could be spread by mosquitoes. Those who had lower education levels were 
more likely to choose the correct answer (Pearson Chi-square, df=12, p=0.02). 
Coughing 
Data showed that (n=177/88.5%) of the participants answered correctly by indicating that 
HIV cannot be spread by coughing and that only (n=20/10%) indicated that it could be 
spread by coughing (Table 4.5).  
The patients’ immune response is lowered when HIV destroys the CD4 cells and 
consequently patients infected with HIV are more susceptible to infections (Harries et al., 
2004:32) such as pulmonary tuberculosis. HIV/AIDS and TB are closely connected, and 
often described as a “dual-epidemic” (WHO, 2004). WHO (2004) also states that TB is one 
of the main causes of death in HIV positive patients. An estimated one-third of the 40 million 
people living with HIV/AIDS worldwide are co-infected with TB and most of them live in Sub-
Saharan Africa (WHO, 2004). 
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Further analysis showed that a statistical association was identified between whether 
coughing spreads HIV and education level (Pearson Chi-square, df=12, p=0.01). 
Blood transfusion 
The question of whether or not HIV could be spread through blood transfusion was chosen 
well with (n=200/100%) correctly indicating that it can (Table 4.5). This result indicated that 
participants were well informed regarding the possible risk for HIV transmission through 
blood transfusion.  
This corresponds with a study conducted by Odu and Akanle (2008:85), where 90% of the 
participants understood the risk for transmission through a blood transfusion. In a study 
conducted by Wesier et al. (2003:283), results also indicated that patients had a good 
understanding of HIV transmission through blood transfusion. 
Infected bodily fluids 
The results showed that the majority (n=188/94%) of the participants correctly indicated that 
HIV can be spread through infected body fluids (Table 4.5). Further analysis showed that 
there was a statistical significant association between gender and whether or not HIV could 
be spread through infected bodily fluids and that males were more likely to indicate correctly 
(Pearson Chi=square, df=1, p=0.03, Fisher’s Exact test one tailed (p=0.02) in the one tailed 
and two tailed (p=0.04)).  
This corresponds with the study by Wesier et al. (2003:283), in which results showed that 
participants understood the risk for HIV transmission through infected body fluids. 
Table 4.5: Is HIV spread through any of the following? 
Variable Yes: n(%) No: n(%) Total: n(%) 
Kissing 7(3.5) 193(96.5) 200(100) 
Hugging 2(1) 198(99) 200(100) 
Sexual activity 198(99) 2(1) 200(100) 
Mosquitoes 20(10) 180(90) 200(100) 
Coughing 23(11.5) 177(88.5) 200(100) 
Blood transfusion 200(100) 0(0) 200(100) 
Contact with HIV positive blood or 
body fluids 
188(94) 12(6) 200(100) 
4.4.3 What is the window period? 
The window period is the gap of approximately 3 months between the time when a person 
becomes infected with HIV and the time when antibodies first appear in the blood (Harries et 
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al., 2004:19). At this time there is a rapid multiplication of the HIV virus which occurs (Cefrey, 
2001:8-9) especially in these first three (3) months (Jehuda- Cohen, 2011:179) which 
increases the risk for transmission to others through sexual intercourse or other ways. 
Data revealed that (n=85/42.5%) knew that it was ‘the period when the HIV virus is not seen 
in the blood’, but (n=107/53.5%) did not know what the window period was at all. A few 
participants (n=5/3%) indicated that the window period is the time ‘when it is safe to have 
unsafe sex’ (Table 4.6). A further analysis showed that there was a statistically significant 
difference between distribution of answers for the window period and language (Pearson 
Chi-squared, df=12, p=0.02). This was a critical question. 
Table 4.6: What is the window period? 
What is the window period? n(%) 
When you get HIV through the air 2(1) 
When HIV is not seen in the blood 85(42.5) 
When it is safe to have unsafe sex 6(3) 
I don’t know 107(53.5) 
TOTAL 200(100) 
4.4.4 How long does the window period last? 
In this particular question, results indicated that (n=106/53%) did not know how long the 
window period lasts. As stated in the 4.4.3, the window period lasts approximately 3 months 
(Jehuda- Cohen, 2011:179). Lack of knowledge for this question could be attributed to the 
fact that (n=115/57.5%) did not know what the window period was or did not answer 
correctly (as discussed in paragraph 4.4.3). Only (n=82/41%) of the participants knew that it 
lasted for three (3) months (Table 4.7). This was a critical question. 
Table 4.7: How long does the window period last? 
How long does the window period last? n(%) 
3 months 82(41) 
6 months 10(5) 
2 years 2(1) 
I don’t know 106(53) 
TOTAL 200(100) 
4.4.5 What is a CD4 count? 
Although being an important test in monitoring the immune status of the patient (Evian, 
2008:26), data showed that (n=142/71%) chose correctly by indicating that a CD4 count is 
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the number of ‘fighter cells’ in the body (Figure 4.6). This corresponds with the study by Wolf 
et al. (2005:870), which revealed that there was a lack of understanding of common 
HIV/AIDS terms such as a CD4 count. A further analysis showed that there is a statistically 
significant difference between the answers to “What is a CD4 count” and language (Pearson 
Chi-square, df=12, p=0.03). This was a critical question. 
 
Figure 4.6: Distribution of answers to the question: What is a CD4 count? 
4.4.6 When last was your CD4 count done? 
Data indicated that most (n=159/79.5%) participants indicated that their last CD4 count was 
done less than 6 months before, (n=26/13%) indicated 6-12 months before and (n=12/6%) 
did not know when their last CD4 count was done (Table 4.8). Statistically significant 
associations were found between literacy level and when last their CD4 count was done. It 
showed that literate participants were most likely to indicate that their CD4 count was drawn 
less than six (6) months ago (Pearson Chi=square, df=6, p=0.01). 
Table 4.8: When was your last CD4 count done? 
Time period n(%) 
<6 months ago 159(79.5) 
6-12 months ago 26(13) 
12-24 months ago 3(1.5) 
I don’t know 12(6) 
TOTAL 200(100) 
4.4.7 How often should you have your CD4 count done? 
The CD4 count is a good test in monitoring the immune status of HIV positive patients 
(Evian, 2008:26). A CD4 count should be done every 6 months prior to starting ART (South 
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Africa, 2010:27). However, the CD4 count must be monitored at 4 months, 12 months and 
then 12 monthly after commencing ART (South Africa, 2010:31). The data revealed that only 
(n=23/11.5%) indicated correctly that a CD4 should be drawn 12 monthly (Figure 4.7). This 
was a critical question. 
 
Figure 4.7: Distribution of answers to the question: How often should a CD4 count be done? 
4.4.8 Why is it important to have your CD4 count done? 
The pharmacological action of ART is to suppress the virus and prevent rapid replication 
thereof (Almeida and Vieira, 2009:184). Consequently, the viral load is decreased in the 
blood and CD4 counts are increased (Evian, 2008:79). Data revealed that (n=139/69.5%) 
participants indicated correctly that it is important to do your CD4 count ‘to see if the ART is 
working’, while (n=39/19.5%) indicated incorrectly that it was important so that one could 
‘monitor the HIV cells in the blood’ (Table 4.9). Further analysis showed a significant 
statistical association between language and why it is important to have your CD4 count 
done (Pearson Chi-square, df=12, p=0.02).  
Table 4.9: Why is it important to have you CD4 count done? 
Reasons for CD4 Count n(%) 
To monitor how many HIV cells you have in your blood 39(19.5) 
To see if you have been cured of HIV 2(1) 
To see if the treatment is working 139(69.5) 
Do not know 20(10) 
TOTAL 200(100) 
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4.4.9 What is a viral load? 
Viral load ‘explains the measurement of the amount of HIV in the blood expressed which 
assists in monitoring the response to treatment’ (Anderson, Keith, Novak & Elliot, 
2002:1813).  
The data revealed that (n=120/60%) of the participants indicated correctly that a viral load is 
‘the number of HIV cells in the blood’, and that (n=69/34.5%) did not know what a viral load 
was (Figure 4.8).This corresponds with the study by Wolf et al. (2005:870), which revealed 
that there was a lack of understanding of common HIV/AIDS terms such as viral load.  
 
Figure 4.8: Distribution of answers to the question: What is a viral load? 
4.4.10 When last was your blood drawn for viral load? 
The response to this question indicated that (n=106/53%) of the participants said that their 
blood for viral load was drawn less that 6 months prior to the interview and (n=77/38.5%) of 
participants did not know when last theirs were drawn (Figure 4.9). Further analysis showed 
a significant statistical association between gender and when last blood was drawn for viral 
load. Women were more likely to know when last their viral load was done, as opposed to 
men (Pearson Chi-square, df=2, p=0.03).  
Stellenbosch University http://scholar.sun.ac.za
 52 
 
 
Figure 4.9: Distribution of answers to the question: When last was your blood drawn for viral 
load? 
4.4.11 Do you know which stage of HIV/AIDS you are in? 
According to Harries et al. (2004:32), the stages of HIV are based on clinical symptoms and 
signs of the disease. The data for this question revealed that only (n=17/8.5%) knew which 
stage they were in and (n=183/91.5%) did not know (Table 4.10). In the researcher’s 
experience, patients are not often educated on their HIV stage in clinical appearance. 
Table 4.10: Do you know what stage of HIV you are currently in? 
Do you know which stage of HIV you are currently in? n(%) 
Yes 17(8.5) 
No 183(91.5) 
TOTAL 200(100) 
4.4.11.1 If  yes, which stage are you in? 
Of the total number of participants (n=200/100%), (n=7/3.5%) indicated that they were in 
stage 1; (n=3/1.55%) indicated stage two and (n=7/3.5%) stage 4 (Table 4.11). 
Table 4.11: Which stage are you in? 
 
 
 
 
Which stage are you in? n(%) 
Stage 1 7(3.5) 
Stage 2 3(1.5) 
Stage 4 7(3.5) 
I don’t know 183(91.5) 
TOTAL 200(100) 
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4.4.12 If you are HIV positive, will your children also definitely be HIV positive? 
This question was answered well with the data revealing that only (n=13/6.5%) of the 
participants incorrectly indicated ‘yes’ and that (n=187/93.5%) indicated correctly by 
choosing ‘no’ (Figure 4.10). According to literature, HIV can be transmitted from mother- to-
child inter-uterine (Evian, 2008:13-17). However, with the help of ART, the risk of mother -to-
child transmission of HIV is reduced by suppressing the mother’s viral load (Zuniga et al., 
2010:145). During pregnancy, women who are not eligible for ART all become eligible from 
14 weeks into the pregnancy (Zuniga et al., 2010:145). This was a critical question. 
 
Figure 4.10: Distribution of answers to the question: If you are HIV positive, will your children 
also definitely be HIV positive? 
4.4.13 Why did the staff at the clinic say that you must start treatment? 
As this was an open-ended question, five (5) themes were identified in the analysed data as 
to the various reasons that participants indicated they had to start ART (Figure 4.11). All 
reasons were valid in layman’s terms except for the answer ‘because I am HIV positive’. As 
discussed in paragraph 2.3.1, there are certain criteria for initiating ART based on clinical 
signs and symptoms of the disease or other evidence of disease progression such as the 
CD4 count (Harries et al., 2004:32) and not just merely for being ‘HIV positive’. 
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Figure 4.11: Reasons for commencing ART 
4.4.14 Can ART cure HIV? 
The data indicated that (n=197/98.5%) chose correctly by indicating ‘no’ and that only 
(n=3/1.5%) indicated ‘yes’, ART can cure HIV (Table 4.12). Studies conducted by Kip et al. 
(2008:152), identified in contrast that there were misconceptions in that some people 
believed that HIV could be cured by ART. Odu and Akanle (2008:85), found that participants 
in their study were confused as to whether or not HIV/AIDS could be cured by spiritual, 
traditional or medical practitioners. This was a critical question. 
Table 4.12: Can ART cure HIV? 
Can ART cure HIV? n(%) 
Yes 3(1.5) 
No 197(98.5) 
TOTAL 200(100) 
4.4.15 What does ART do to the HIV virus in the body? 
Although not a cure, antiretroviral therapy (ART) is used to assist in decreasing the 
replication of the HIV virus within the body and usually results in near-complete suppression 
of HIV replication (Harries et al., 2004:137). 
Data showed that (n=189/93.5%) of the participants indicated correctly by choosing ‘lowers 
the viral load’ (Figure 4.12). In contrast, studies conducted by Mukona et al. (2011:19), 
indicated that only 69.4% of their participants understood the function of ART. Similarly to 
the latter, Almeida and Vieira (2009:184), showed in their studies that 45% of the HIV 
positive participants on ART knew how ARVs worked. It raises a concern that (n=2/1%) 
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stated that ART makes it ‘safe to have unsafe sex’ (sex without a condom). This was a 
critical question. 
 
Figure 4.12: Distribution of answers to the question: What does ART do to the HIV virus in the 
body? 
4.4.16 Did the clinic staff say that you can expect any side-effects with your 
medication? 
The data analysis showed that (n=122/61%) of the participants indicated that they had been 
educated on side-effects while (n=78/39%) indicated that they have not received any 
education on side-effects. According to the HIV/TB guidelines for the Western Cape 
(2010:31), routine care given at every follow-up visit includes asking about any drug related 
side-effects. This should be done at every visit. A statistical significant difference between 
gender and whether the clinic staff told the participants that they could expect any side-
effects with the medication was shown. Females were more likely to indicate ‘yes’ to 
receiving education on side-effects as opposed to males (Pearson Chi-square, df=1, 
p=0.01and Fisher exact, 1 tailed, p=0.05, and 2 tailed, p=0.01).  
In addition, further analysis also showed a statistically significant difference between the 
length of time on ART and whether the clinic staff told the participants that they could expect 
any side-effects with the medication. Data indicated that the longer the person was on ART, 
the more likely they would indicate that they did receive education on side-effects (Pearson 
Chi-square, df=3, p=0.04) (Figure 4.13).  
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Figure 4.13: Distribution of years on ART specific answers to: Did the clinic staff say that you 
could expect any side-effects with the medication you are using? 
4.4.17 Can ART cause side-effects that can be very dangerous? 
Data revealed that only (n=73/36.5%) correctly indicated that ART could cause dangerous 
side-effects and that (n=127/63.5%) of the participants indicated that they could not (Table 
4.13). According to the HIV/TB guidelines for the Western Cape (2010:31), routine care 
given at every follow-up visit includes asking about any drug related side-effects which also 
include the dangerous side–effects such as skin rash, vomiting and jaundice. In such cases, 
these patients are immediately referred to the doctor or to the hospital. This was a critical 
question. 
Table 4.13: Can ART cause side-effects that can be very dangerous? 
Can ART cause side-effects that can be very dangerous? n(%) 
Yes 73(36.5) 
No 127(63.5) 
TOTAL 200(100) 
4.4.18 Can you name two (2) danger signs of ART? 
The data revealed that only (n=21/10.5%) of the participants could name two (2) danger 
signs of ART either skin rash, jaundice or vomiting. Table 14.4 indicates how many of the 
total (n=200/100%) participants could name each of the following as danger signs. This was 
a critical question. 
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Table 4.14: Can you name two danger signs of ART? 
Danger Sign Could identify n(%) Could not identify n(%) Total n(%) 
Skin Rash 60(30) 140(70) 200(100) 
Jaundice 1(0.5) 199(99.5) 200(100) 
Vomiting 26(13) 174(87) 200(100) 
4.4.19 What should you do if you experience any of the danger signs? 
In the researcher’s experience, patients are educated to stop all medication and go to the 
clinic as soon as possible, as danger signs could be an indication of potentially life 
threatening side-effects of ART. These patients (depending on severity) should immediately 
be referred to the doctor (Zuniga et al., 2010:223-229). However, the data revealed that the 
majority (n=126/63%) correctly indicated that they ‘must stop their medication immediately’ 
and ‘go to the clinic as soon as possible’ (Figure 4.14). However, (n=7/3.5%) indicated that 
they must ‘carry on taking the medication until the symptoms go away’ and (n=66/33%) did 
not know what they should do in such a case. Further analysis indicated that there was a 
statistically significant association between ‘what should you do if you experience danger 
signs’ and language (Pearson Chi-square, df=12, p=0.03).This was a critical question. 
 
Figure 4.14: Distribution of the answers to the question: What should you do if you experience 
any of the danger signs? 
4.4.20 What should you do if you forget to take your medication? 
According to the data, (n=153/76.5%) correctly indicated that they should drink the skipped 
dose immediately when they remember (Figure 4.15). However, (n=26/13%) of the 
participants incorrectly indicated that they should throw the skipped medication away and 
carry on as usual and (n=20/10%) stated that they should take the skipped dose together 
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with the next dose. According to Bangsberg (2006: 939), an adherence rate of more than 
90% needs to be maintained in order for ART to be effective in achieving and maintaining 
viral suppression. 
When compared with studies by Almeida and Vieira (2009:184) in Brazil, it was found that 
only 14% of their participants did not know what to do if a dose was skipped, which indicates 
a higher level of understanding by the participants in Brazil than those in this study. Further 
analysis showed a statistical significant difference between the ‘years on ART’ and what 
should be done if medication was forgotten. The longer the patients were on ART the more 
likely they were to know what to do if they had forgotten their medication (Pearson Chi-
square, df=9, p=0.01). This was a critical question. 
 
Figure 4.15: Distribution of answers to the question: What must you do if you forget to take 
your medication? 
4.4.21 What will happen if you stop taking your medication? 
Data for this specific question revealed that (n=189/94.5%) of the participants correctly 
indicated that ‘the ART will become less effective and the HIV will increase in your blood’ 
(Figure 4.16). This result is in contrast to the results in studies conducted by Mukona et al. 
(2011:19), which revealed that participants’ knowledge of the effects of poor adherence was 
low. This was a critical question. 
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Figure 4.16: Distribution of answers to the question: What will happen if you stop taking your 
medication? 
4.4.22 Where did you learn most of your knowledge about HIV and treatment 
from? 
Data revealed (Table 4.15) that (n=167/83.5%) learnt most of their knowledge from the 
“clinic sister”, as opposed to the doctor (n=11/5.5%). This corresponds with previous studies 
by Weiser et al. (2003:284), who revealed that nurses and physicians were the primary 
source of support for patients suffering from HIV/AIDS. 
Table 4.15: From where did you learn most of the knowledge about HIV and its treatment from? 
Source of knowledge about HIV and treatment n(%) 
The HIV sister at the clinic 167(83.5) 
Posters in the clinic 6(3) 
TV and radio 9(4.5) 
Books in the clinic 3(1.5) 
A family member or friend 1(0.5) 
The doctor 11(5.5) 
Other 3(1.5) 
TOTAL 200(100) 
4.5 DISTRIBUTION OF OBTAINED SCORES 
Scores for the 14 critical questions (Table 4.16: y-axis) revealed that (n=0/0%) of the 
participants had good knowledge, (n=40/20%) of the participants had average knowledge 
and (n=160/80%) of the participants had poor knowledge. The average score for all 
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participants for all 20 knowledge testing questions, including the ‘good to know’ questions 
(Table 4.16: x-axis), was (12.6/63%). All scores are represented in Table 4.16. 
Table 4.16: Distribution of scores 
                          
  Number of participants Scoring legend 
  
N
um
be
r o
f c
rit
ic
al
 a
ns
w
er
s 
co
rr
ec
t 
14 0 0 0 0 0 0 0   Good 
  13 0 0 0 0 0 8 0   Average 
  12 0 0 2 0 1 6 0   Poor 
  11 0 0 5 0 3 14 1   
  10 0 0 1 7 9 13 3   
  9 0 0 4 2 8 19 0   
  8 0 0 6 5 8 10 2   
  7 0 0 4 10 6 7 1   
  6 0 3 4 6 2 5 1   
  5 0 2 3 3 2 0 0   
  4 0 1 1 1 0 1 0   
  3 0 0 0 0 0 0 0   
  2 0 0 0 0 0 0 0   
  1 0 0 0 0 0 0 0   
  0 0 0 0 0 0 0 0   
    0 1 2 3 4 5 6   
  Number of non-critical answers correct   
                          
 
4.6 SUMMARY 
The participants in this study were mainly female (n=145/72.5%), and the mean age was 
37.5 years. Participants were mostly Xhosa speaking and literate, and the majority 
(n=112/56%), of the participants had an education level between grade 9 and grade 12. The 
majority (n=73/36.5%) of the participants had been living with HIV for more than 5 years, but 
had been on ART for between 1 to 3 years. The researcher assessed the participant’s 
knowledge by asking questions about various aspects of HIV and ART throughout the study.  
All the data collected during this research study was analysed, interpreted and discussed. 
The researcher succeeded in exploring, investigating and addressing the research question, 
i.e.: “What is the knowledge of infected HIV/AIDS patients who are receiving ART about 
HIV/AIDS and ART?”  
By using scientific, investigative techniques, the participant’s knowledge of HIV/AIDS and its 
treatment were tested and determined and independent and dependent variables were 
correlated to determine significant statistical associations between these variables. The goal 
and the objectives set for this study were therefore reached. 
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The results showed that participant’s knowledge of HIV/AIDS is poor, as revealed by the 
scoring system, and that there are also some misconceptions regarding HIV/AIDS and ART. 
The ability for self-care is thus compromised and by not having knowledge and regular 
education, HIV positive people in the community will not be motivated, prepared and 
informed (Epping-Jordan et al., 2004:301) enough to apply to the ICCC framework in caring 
for chronic conditions such as HIV/AIDS.  
 
The following objectives were therefore successfully identified and examined namely, to 
 evaluate the level of knowledge of patients infected with HIV/AIDS about the disease 
 evaluate the level of knowledge of patients infected with HIV/AIDS about ART 
 establish whether there were statistical differences between the independent and 
dependant variables within the study.. 
In the final chapter, recommendations are made, based on the findings, as well as the study 
outcomes being generated during this research. 
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CHAPTER 5: DISCUSSION, CONCLUSIONS AND 
RECOMMENDATIONS 
5.1 INTRODUCTION 
In this chapter, conclusions, based on the scientific evidence being obtained during this 
study, are drawn, with reference to the outcomes from similar studies. The conclusions are 
discussed according to the purpose, research question and objectives set for the study, 
based on the findings. Areas for further research and the limitations of the study are 
discussed. Recommendations to facilitate improved knowledge of HIV/AIDS and its 
treatment of those HIV positive patients on ART, are also presented.  
5.2 DISCUSSION 
5.2.1 The level of knowledge of patients infected with HIV/AIDS about the 
disease 
The participant’s knowledge of HIV/AIDS was tested on various levels which will be 
discussed in turn. 
The majority of the participants were female (n=145/72.5) (paragraph 4.3.2) which is 
supported by the UNAIDS 2007 AIDS Epidemic Update (2007:8) which states that more 
women are living with HIV/AIDS than men are, and that (n=150/75%) (paragraph 4.3.3) of 
the participants who attended the clinic in which data collection was being conducted, were 
Xhosa speaking. The mean age was 37.5 years and although the study was conducted in a 
low socio-economic area, (n=196/98%) were literate (paragraph 4.3.5) and most 
(n=157/78.5%) had a highest education level between grade 8-12 (paragraph 4.3.4). 
Knowledge regarding the action of HIV compromising the immune system was only 
answered correctly by (n=114/57%) of the participants (paragraph 4.4.1), and many of the 
participants thought HIV merely destroys your organs. This reveals that this basic knowledge 
of HIV is not fully understood by these participants suffering from HIV/AIDS. 
The spread of the HI-virus was relatively well understood by most of the participants 
(n=160/88%) in that the correct answer was chosen most times. However, the only mode of 
transmission which was answered (n=200/100%) correctly was transmission through blood 
transfusion (paragraph 4.4.2). This corresponds with a study conducted by Odu and Akanle 
(2008:85), where 90% of the participants understood the risk for transmission through a 
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blood transfusion, as well as studies conducted by Weiser et al. (2003:283), in which results 
also indicated that patients had a good understanding of HIV transmission through blood 
transfusion. 
 What is a concern however, is that (n=2/1%) of the participants indicated that HIV cannot be 
spread through sexual intercourse (paragraph 4.4.2) this included a male and female, and 
(n=12/6%) stated that HIV cannot be spread through HIV infected body fluids (paragraph 
4.4.2), of which females were more likely to give the incorrect answer (p=0.03). This is an 
important finding as females must know the risk when breastfeeding their babies, as breast 
milk is a bodily fluid, which places the baby at risk of being infected with HIV if not breast fed 
exclusively. Weiser et al. (2003:283), also indicated that results from their studies showed an 
understanding for risk of HIV transmission through infected bodily fluids. According to Evian 
(2008:13-17), sexual intercourse, blood transfusion, mother to child transmission (MTCT) as 
in during pregnancy, birth and breast feeding are the modes of transmission of HIV. 
A significant association (p=0.04) was found between hugging and HIV transmission 
(paragraph 4.4.2). The older participants were under the impression that HIV could be 
spread through hugging as the mean age for the incorrect answers given was 50.5 years 
(p=0.04). Many (n=23/11.5%) indicated that HIV could be spread through coughing 
(paragraph 4.4.2), which could be influenced by the link between HIV/AIDS and TB (WHO 
2004). Furthermore, (n=20/10%) of the participants believed that HIV could be spread 
through mosquitoes (paragraph 4.4.2), which differs from the study conducted by Nachega 
et al. (2005:189) in Soweto, where 60% of the participants indicated that HIV could be 
spread by mosquitoes.  
The knowledge of the window period was poor, only (n=85/42.5%) of the participants knew 
what it was (paragraph 4.4.3), and (n=107/53.5%) did not know at all. As the window period 
is a very high risk period just after transmission of the HIV virus, it is important for individuals 
to know what it is and to also know that just because a sexual partner’s test is negative it 
does not necessarily mean that they are HIV negative, as they could be in the window 
period. This 3 month period is the most risky to an HIV negative partner as there is a high 
risk of the virus to be transferred to them by an undiagnosed infected partner (Jehuda-
Cohen, 2011:179). 
Patients get very confused with the difference between a CD4 count and a viral load. Only 
(n=142/71%) of the participants knew what a CD4 count was and (n=31/15.5%) of the 
participants confused it with the viral load (paragraph 4.4.5). When the viral load knowledge 
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was tested, only (n=120/60%) of the participants indicated it correctly (paragraph 4.4.9). The 
majority (n=159/80%) of the participants knew when last their CD4 count was done 
(paragraph 4.4.6), and many during the interviews could tell the researcher what their last 
count amount was (although not recorded for data collection purposes). Most participants 
(n=159/79%) indicated that their CD4 count should be done 6 monthly (paragraph 4.4.7), 
which does not correspond with the Western Cape HIV/TB Guidelines (2010:31), which state 
that it should be done 12 monthly after being on ART for more than a year.  
It is important that a CD4 count and viral load should be done, as the result gives a good 
indication of the progression of the disease of the, immune system (Evian, 2008:26) and also 
whether or not the ART is effective. Only (n=139/69.5%) of the participants knew why it is 
important to have a CD4 count done (paragraph 4.4.8). The researcher believes that if 
patients do not know what a CD4 count or viral load is, they will not fully understand the 
importance of monitoring it regularly.  
In the researchers experience, patients are not often educated about their HIV stage which 
was confirmed in this study, as (n=183/91.5%) of the participants did not know which HIV 
stage they were in (paragraph 4.4.11). 
Participants were mostly aware that HIV could be transferred inter-uterine, however 
(n=187/93.5) also knew that they could still have HIV negative children with the help of ART 
(paragraph 4.4.12). According to literature, HIV can be transmitted from mother-to-child 
inter-uterine (Evian, 2008:13-17). However, by taking ART as prescribed, the risk of mother-
to-child transmission of HIV is reduced by reducing the mother’s viral load (Zuniga et al., 
2010:145). 
In conclusion, the objective was scientifically investigated and the knowledge of participants 
about HIV/AIDS was successfully evaluated. The study results show that there are some 
misconceptions regarding HIV/AIDS. In paragraph 5.4 the levels and scores obtained about 
their knowledge are discussed. 
5.2.2 The level of knowledge of patients infected with HIV/AIDS about ART 
Themes were identified for reasons why participants commenced on ART, such as a low 
CD4 count, they were sick, TB, pregnancy and because of being HIV positive (paragraph 
4.4.13). It is interesting to note that as mentioned in paragraph 4.4.5, (n=142/71%) knew 
what a CD4 count was, and that (n=160/80%) said that they were placed on ART due to a 
low CD4 count (paragraph 4.4.13).  
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Participants knew (n=197/98.5%) that ART could not cure HIV/AIDS and treatment was most 
likely to be lifelong (paragraph 4.4.14). People with higher education levels were more likely 
to indicate the question correctly (p=0.02). Studies conducted by Kip et al. (2008:152) 
identified in contrast that there were misconceptions in that some people believed that HIV 
could be cured by ART. Odu and Akanle (2008:85), found that participants in their study 
were confused as to whether or not HIV/AIDS could be cured by spiritual, traditional or 
medical practitioners. 
Almeida and Vieira (2009:184) found that 55% of the participants in their study did not know 
that ART supresses viral replication and thereby reducing the viral load in the blood and the 
progression of the disease. This study showed however that (n=189/93.5%) of the 
participants understood the function of ART (paragraph 4.4.15). What is a point of concern is 
that, although minimal, (n=2/1%) of the participants indicated ART has the function of 
making unprotected sex, safe (paragraph 4.4.15). 
Education on side-effects seemed to be lacking in that (n=78/39%) of the participants 
indicated that they had not had any education on the side-effects of ART (paragraph 4.4.16) 
and that (n=127/63.5%) indicated that ART does not cause any dangerous side-effects 
(paragraph 4.4.17) which showed a statistical difference with gender (p=0.01). Further 
analysis showed that participants were more likely to know that ART caused dangerous 
side-effects marked by danger signs and that there was a statistical difference with number 
of years on ART (p=0.04), indicating the longer participants were on ART, the more likely 
participants were to know that ART had dangerous side-effects marked by danger-signs. 
Studies have shown that there are numerous side-effects as identified by Bhengu et al. 
(2009:5), however in this study only (n=21/10.5%) could name two danger signs (paragraph 
4.5.18). Although not all participants could name danger signs, (n=126/63%) they knew that 
if danger signs did occur that they should stop the medication and go to the clinic as soon as 
possible (paragraph 4.4.19), however (n=66/33%) did not know what to do at all. This is 
important as skin rash, vomiting and jaundice are indications of serious complications of 
ART to the degree that if not identified and managed, any of these could be fatal (Zuniga et 
al., 2010:163). 
As mentioned in paragraph 4.4.20, medication needs to be completely adhered to no less 
than 90% of the time (Bangsberg, 2006:939), and therefore needs to be taken as prescribed, 
as poor adherence could lead to ART drug resistance. Patients must understand what to do 
should they forget to take a tablet at the right time. Fortunately, most (n=153/76.5%) of the 
participants knew that if they forget their medication (paragraph 4.4.20), that they should 
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take it as soon as they remember. Results also showed that there were statistical differences 
between action if medication was forgotten and length of time on ART. Data revealed the 
longer the participants were on ART, the more likely they were to know what they should do 
if they forget to take their medication (p=0.01). 
However, (n=47/23.5%) of the participants did not know what to do if they skipped a dose of 
their medication (paragraph 4.4.20). With only 76.5% knowing how to react on a skipped 
dose, it indicates that 23.5% of the population studied is at high risk for developing drug 
resistance (Zuniga et al., 2010:163). When compared with the study conducted by Almeida 
and Vieira (2009:184) in Brazil, it was found that only 14% of their participants did not know 
what to do if a dose was skipped, it indicates a different level of knowledge by the 
participants in Brazil than those in this study. 
 The majority (n=197/98.5%) of participants indicated that ART did not cure HIV (paragraph 
4.4.13). When given the question ‘what will happen if you stop taking your medication?’ 
(n=189/94.5%) of the participants correctly indicated that ‘the ART will become less effective 
and the HIV will increase in your blood’ (paragraph 4.5.21). Mukona et al. (2011:19) in their 
study found that participant’s knowledge regarding the effects of failing to adhere to 
medication was low. 
When asked where they had received most of their HIV/AIDS knowledge, most 
(n=167/83.5%) of the participants indicated that they received it from the “HIV sister in the 
clinic” (paragraph 4.4.22). This corresponds with the study by Weiser et al. (2003:284), who 
stated that the nurse is one of the primary sources of support for patients suffering from 
HIV/AIDS. 
In conclusion, the objective was scientifically investigated and the knowledge participants 
had about ART was successfully evaluated. Study results indicated that misconceptions 
regarding ART do exist. In paragraph 5.4 the levels and scores obtained about their 
knowledge are discussed. 
5.2.3 Determining whether there are statistical differences between the 
dependant and independent variables within the study 
Statistically significant associations were made between the independent and dependant 
variables within the study i.e. the longer the participants had been on ART, the more likely 
they were to to take the correct action if they forgot to drink their medication (p=0.01). 
Differences were determined between genders, language, education level, literacy level, 
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period of time living with HIV, as well as length of time on ART which have been reported on 
in paragraphs 5.2.1 and 5.2.2. 
In conclusion, results indicated that variables such as gender, language, education level, 
literacy level, period of time living with HIV and length of time on ART did have an influence 
on how much knowledge and understanding participants had of HIV/AIDS and ART. 
5.3 CONCLUSIONS 
The specific objectives set for this study were to 
 evaluate the level of knowledge of patients infected with HIV/AIDS about the disease 
 evaluate the level of knowledge of patients infected with HIV/AIDS about ART 
 establish whether there are statistical differences between the dependant and 
independent variables within the study. 
These objectives were met through an in-depth research study which aimed at evaluating 
what the knowledge is of infected HIV/AIDS patients who are receiving antiretroviral 
treatment, regarding HIV/AIDS and antiretroviral therapy (ART). 
5.4 OVERALL EVALUATION OF PARTICIPANT’S KNOWLEDGE REGARDING 
HIV/AIDS AND ANTI-RETROVIRAL THERAPY (ART) 
Analysis of the data revealed that the average score of all participants for all 20 knowledge 
testing questions in the questionnaire, including the ‘good to know’ questions, was 
(12.6/63%). Analysis of the 14 critical questions revealed that (n=0/0%) of the participants 
had good knowledge, only (n=40/20%) of the participants had average knowledge and 
(n=160/80%) of the participants had poor knowledge as explained in paragraph 4.5.  
According to Smith Fawzi et al. (2006:769), patients with inadequate knowledge of HIV/AIDS 
and transmission thereof are more likely to report not taking ART in order to be effective in 
achieving and maintaining viral suppression, which needs an adherence rate of no less than 
90% (Bangsberg, 2006: 939). Health knowledge is one of the strongest predictors of health 
status and wellbeing (Nath, 2007:44) and the lower the literacy, the poorer the 
understanding which results in poorer adherence (Wolf et al., 2005:864). It is clearly 
indicated in the results as stated above that the knowledge of basic HIV/AIDS and ART 
information is poor and therefore nurses need to pay more attention to patient education. 
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5.5 RECOMMENDATIONS  
The recommendations are presented according to the results that have emerged from the 
study. 
What has emerged from this study is that the patient HIV/AIDS education which is currently 
being performed at this CHC is ineffective. The scores for the study revealed that out of a 
total of (n=200) participants not one participant was able to achieve a good score for basic 
questions regarding HIV/AIDS and ART. Due to the fact that some participants believed that 
HIV/AIDS can be transmitted by mosquitoes and hugging a HIV positive individual, including 
that ART makes unsafe sex safe, are clearly indicative of the lack of knowledge in the 
spread and management of HIV/AIDS. These are serious misconceptions which need to be 
addressed. 
The researcher has observed in her practice that due to the large amount of patients coming 
into CHCs daily and the low staff capacity to treat all of these patients, nurses are not able to 
spend quality time in educating and supporting patients as they need to. Nurses are required 
to see many patients in minimum time, with limited resources at times 
Education should be continuous from the day the individual is diagnosed with HIV onwards. 
The study showed (as discussed throughout chapter 4) that it should not be assumed that 
patients are well informed as they have had HIV for a long time or have been on treatment 
for a long time.  
Patient education can be rendered in various ways within the community setting. The 
following are recommendations for how various patient education methods can be 
implemented in the community namely: 
5.5.1 Continuous patient education 
Education needs to start in the consultation room and needs to continue outside the 
consultation room. Patients need to have adequate time to ask questions and raise any 
concerns during a consultation and nurses need to be able to give that education, support 
and attention to patients without feeling pressed for time. More nurses need to be employed 
by the state in order to reduce the workloads within the CHCs. In this way more time can be 
dedicated to educating patients. As stated by Mash, Blitz, Kitshoff and Naudé (2010:107), 
the communicator or nurse within the clinical context, is there to promote a healthy lifestyle 
by explanation and being an advocate for the individual, thereby helping individuals and 
groups to improve and protect their own health. 
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5.4.1.1 Language and culture 
The PHC nurses should be aware of the dominant language, culture and religion of the 
communities they serve as these factors play a role in patient education. Services provided 
in the clinic should meet the needs of all patients. Nurses should therefore be able to 
educate and communicate with all people who enter the consultation room or the CHC. In 
this study, a wide range of languages and cultures were represented within one community 
and it was identified that knowledge differed in the different language groups. Nurses and 
educators need to indentify and take cognizance of the language differences of the patients 
they educate. Patients should be provided with the opportunity to be educated in their own 
language, even if that includes relying on a reliable translator to ensure that knowledge is 
sufficiently transferred from the nurse or educator to the patient. All educational material 
should be available in all languages represented in the community. 
5.5.1.2 Gender 
It was observed that men and women often differed in the way they answered questions. 
Men and women have diverse roles within the relationship context. Nurses need to take note 
of who they are educating and what role each individual plays within relationships. Thus they 
need to educate appropriately and give the necessary support.  
Males may learn more effectively from other males instead of a female, therefore it is 
recommended that if an opportunity for education is arranged in group form, males and 
females could be divided into separate groups with a facilitator of their own gender. Different 
modes of learning can be presented in these different groups such as visual, aural or 
reading and writing, suited to the needs of the patients. This is substantiated by studies 
conducted by Wehrwein, Lujan and DiCarlo (2006:155), who observed that males and 
females preferred different modes of learning. Males preferred multi-modal ways of learning 
whereas females, uni-modal. This can be applied in the various groups. Various modes of 
learning can be applied to the male group and single modes of learning to the female group.  
Separate groups may consequently also provide a secure environment, where men and 
women can voice their concerns and ask sensitive questions separately, which they may not 
have asked if the other sex was in the group. However, caution should be taken by 
facilitators that all information given to patients must be coherent.  
5.5.1.3 Age 
It should be taken into consideration when educating patients that the age of the patient 
plays a role. Younger individuals may learn differently from older individuals. Physical 
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abilities such as hearing and vision may be affected with age and therefore, younger 
individuals may learn quicker while the older ones may learn slower. More time might need 
to be spent with older individuals in repeating and making sure they understand the 
information being conveyed to them. Factors such as hearing and vision may play an 
increasing role in patient education of the older patient. 
5.5.1.4 Literacy and Education Level 
Measures need to be implemented to accommodate the education levels of the patients and 
whether patients are literate or not. It may be beneficial to use visual materials, such as 
pictures and videos to demonstrate and explain various aspects of HIV/AIDS and ART. 
Information should be presented in a visual and audible manner in addition to pamphlets 
given to patients of low education and literacy level. 
5.5.2 Visual techniques and initiatives 
Patient education needs to be implemented in all areas of the CHC, such as in all the waiting 
room areas. Most times patients and their companions sit for many hours in the waiting room 
on the days they come for a consultation. This presents an ideal opportunity for education in 
the form of videos or presentations.  
Rosters can be compiled for daily presentations of basic HIV/AIDS education where 
informed, motivated and prepared CNPs or any of the nursing staff are given the opportunity 
to use their creative talents in educating various people about the principles of HIV/AIDS. All 
students from the health disciplines may be utilized in these areas, as most CHCs have 
students present at any given time throughout the year. Each discipline has specific aspects 
about HIV/AIDS that they emphasize such as the importance of diet given by dietitians. 
Additionally, an opportunity for job creation can be made where community workers are 
trained about HIV/AIDS and can then be employed on a part-time basis to run educational 
presentations and programmes within the CHC.  
During the time patients and companions sit in the waiting room, visual material will provide 
the perfect means of passive learning. Posters and pamphlets can be displayed and made 
available for all to read and look at within this area of the CHC including television and digital 
videos. This will increase visual learning for patients and therefore learning will not be 
restricted to the time limits that restrain nurses in their consultation rooms. Mansoor and 
Dowse (2007:37) substantiate the advantages of visual learning who found that patients 
gained more knowledge through simple pamphlets with many pictograms and minimal text, 
as opposed to pamphlets with text only as not all patients can read. 
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Small initiatives such as simple, colourful and eye-catching medicine labels or stickers can 
be designed and added into or pasted onto to medicine containers to promote awareness of 
aspects such as danger signs or what to do in the case of a missed dose. These stickers 
can be made available in all presenting languages, which give different hints or ‘did you 
know’ information for patients to be aware of. Numerous stickers with various information 
can be made so that patients can get a different sticker every month. Wolf, Davis, Bass, 
Curtis, Lindquist, Webb, Bocchini, Bailey and Parker (2010:54), found in their studies that 
simple messages on tablet containers significantly improved patients adherence to treatment 
regime and improved their understanding. 
5.5.3 Continuous professional development 
As HIV/AIDS is an ever changing epidemic, nurses need to have regular updating regarding 
the changes and developments of HIV/AIDS and ART care, as most (n=167/83.5%) 
participants in this study received their HIV/AIDS and ART knowledge form the registered 
nurse. Regular opportunities need to be presented to staff for additional training and 
updating in order for them to be well informed and motivated to convey relevant and 
important information to patients as per the ICCC framework (discussed in paragraph 
1.11.1). In-service training needs to be conducted within the CHC, where managers convey 
their knowledge to their staff. This will in turn facilitate updating and refreshing of staff 
knowledge on a regular basis. 
5.5.4 Community development 
According to the ICCC framework, key figures such as church, spiritual and family leaders 
play significant roles in the community members’ lives (Epping-Jordan et al., 2004:301), and 
therefore an effort should be made to educate these leaders on HIV/AIDS and ART, and to 
inform them of misconceptions and challenges that nurses are facing with their patients in 
the CHC. These leaders will then be motivated, informed and equipped with the necessary 
skills to provide education outside the CHC to patients and community members with whom 
they have a relationship and have great influence. 
5.5.5 Patient acknowledgment 
Public acknowledgment and honour should be given to those patients who are adherent to 
all aspects of their treatment. They could possibly be provided with a certificate of good 
adherence or a prize, which will motivate others to achieve the same. Regular opportunities 
should then be created for these individuals to tell their stories and explain how they 
overcame their challenges to patients in the clinic. In doing so, this may provide a platform 
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for patients to identify with someone who is in the same situation as them, how to cope in 
their own situation and how to overcome their individual and unique challenges. 
5.5.6 Health promotion 
Health promotion provides a platform for wide-spread learning. In the researcher’s 
experience, a well-advertised health promotion day is a way of reaching and educating many 
people at the same time from all areas of the community. Health promotion days can be 
advertised by means of visual posters outside the clinic prior to and on the day of the health 
promotion or marches through the streets to attract people. Announcements can be made on 
local radio stations, where all information regarding the activities is given and community 
members are invited to the day. Health promotion days can be made attractive to the 
patients, by making use of various resources. Sponsorships for food and entertainment can 
be arranged, and various non-governmental organizations can be approached in educating 
patients about safe sex options. Various members of the multidisciplinary team such as the 
pharmacist and occupational therapist can be approached to give their input for the day, by 
educating on drug side-effects and providing information to patients on where they can 
attend support groups. Students in the clinic or HIV/AIDS infected patients can be 
approached to conduct role plays or short ‘skits’ to educate participants. Guest speakers, 
such as doctors, academics and AIDS activists from various organizations can be 
approached to educate on different aspects of HIV/AIDS and treatment.  
Such days can be planned in line with the health calendar, for example the World AIDS day 
on 1 December every year. 
According to Zweigenthal, Puoane, Reynolds, London, Coetzee, Alperstein, Duncan, Atkins, 
Loveday, Hutchings, Geiger, Petersen, Ferguson, Hewett and Batley (2009:157), one of the 
main features of health promotion is that it equips people and communities to practice self- 
control and it empowers them.  
5.6 FURTHER RESEARCH 
More research is needed in evaluating knowledge of HIV/AIDS and its treatment. This study 
needs to be implemented in other low socio-economic communities, as well as more affluent 
communities, to see which variables influence knowledge, and how they compare. 
It is also suggested that further research needs to be done into evaluating the knowledge of 
people who have not been diagnosed with HIV/AIDS. Preventing the spread of HIV is heavily 
influenced by understanding safe-sex practices and understanding the modes of 
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transmission of the virus. This knowledge is therefore crucial for non-HIV suffering 
individuals to know and understand. 
Additionally, more research needs to be conducted in order to establish and evaluate the 
HIV/AIDS and ART knowledge of registered nurses and CNP’s working in the ART clinic, as 
they play the biggest role in the education of HIV positive patients. 
5.7 LIMITATIONS 
According to Burns and Grove (2007:545), limitations are the ‘theoretical and methodological 
restrictions in a study that may decrease the generalizability of the findings.’ 
This study focused on the patients at Delft Community Health Centre only, and did not 
include any other community. It was limited to the Cape Metropole area, and therefore 
cannot be generalized.  
The research was delayed, as the application to do research in a government facility took 
three (3) months to obtain. The data collection was a slow process due to the fact that each 
participant needed to be interviewed individually. 
5.8 CONCLUSION 
In this chapter, the findings were discussed in relation to the objectives set out in the study. 
The purpose of the study was to explore and evaluate the knowledge of HIV/AIDS infected 
patients on ART of HIV/AIDS and its treatment. This chapter showed that the aim was 
achieved. The findings show that the overall knowledge (n=160/80%) is poor. Basic terms 
and principles of HIV/AIDS and ART are not understood and serious misconceptions 
regarding the disease were revealed.  
Patient education is vital as patients are enabled to take the information, carry the 
knowledge with them and render self-care based on what they know and have learnt. 
However, in this study, it is clear that knowledge and understanding are poor. Nurses need 
to take up the role as a supportive-educative medium for the patient, by educating the 
patient and equipping them to make informed decisions based on what they know and 
understand and promote self-care rather than making decisions on behalf of the patient. 
Nurses however, as per the ICCC framework (as discussed in paragraph 1.11.1), need to be 
informed, motivated and prepared to convey information and to educate patients. By 
identifying the patient’s self-care shortcomings as discussed in paragraph 4.8.1, nurses can 
decide which support modality is needed to promote self-care and compliance, and they can 
then give education and support as the patient requires. Additionally, in line with the ICCC 
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framework leaders in the community also need to be equipped with the skills to support, 
motivate and knowledge to educate members of the community about HIV/AIDS.  
Education and health promotion empower people to take control of their own lives and their 
own health and create an environment which support healthier lifestyles and informed 
decision making based on knowledge and understanding. Ultimately this may contribute to 
an improvement in the quality of life of HIV/AIDS infected patients and a decrease in the 
rapid spread of this disease.  
Recommendations are based on the findings which indicate that increased patient education 
is needed in the clinical setting. As South Africa constitutes 17% of the global HIV/AIDS and 
the number of people living with HIV/AIDS has shown a constant increase every year since 
the first diagnosis of HIV/AIDS in the 1980’s (South Africa, 2007:11), measures to improve 
patient education need to be developed and implemented as soon as possible, especially 
since the research shows that patient knowledge is poor. Education is essential in facilitating 
the patient in helping to become a mature individual who is able to make informed decisions 
regarding his/her own health and wellbeing.  
Further research is recommended as explained in paragraph 5.6 to overcome the limitations 
which were identified in this study. 
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APPENDICES 
APPENDIX A: DATA COLLECTION TOOL 
The knowledge about HIV/AIDS and Antiretroviral treatment of patients 
receiving antiretroviral therapy 
 
Study Aim 
The purpose of this study is to determine the knowledge of infected HIV/AIDS patients who 
are receiving antiretroviral medication about HIV/AIDS and ART. 
Dear Participant 
Thank you for agreeing to voluntarily participate in this study. The information that you 
provide is very valuable, and in providing the information, you are helping to make this study 
a success. Therefore it is important that you answer honestly and accurately. Your 
contribution is valued. 
All information will be treated confidentially and the researcher undertakes not to reveal any 
information in this questionnaire at any time. 
This structured interview will take approximately 20 minutes to complete. 
 
Yours Sincerely, 
Lauren Terblanche 
Cell: 0845511588 
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SECTION A: DEMOGRAPHIC DATA  
Please complete the entire questionnaire by marking the appropriate answer with an x 
Correct answers typed in bold. Critical Questions marked with an asterisk (*).  
1. Age: ................................................... 
 
2. Gender 
Male (M)  
Female (F)  
 
3. Language 
1. English  
2. Afrikaans  
3. Xhosa  
4. Zulu  
5. Other (please specify)  
 
4. What is your highest level of education achieved? 
.................................................. 
 
5. Are you able to read and write? 
1. No 
2. Write only 
3. Read only 
4. Read and write 
 
6. How long have you been living with HIV? 
1. Less than a year  
2. > one and ≤ three years  
3. > three and ≤five years  
4. >five years  
 
7. How long have you been on treatment for HIV/AIDS (ART)? 
1. Less than a year  
2. ≥ one and < three years  
3. >three and  ≤ five years  
4. >More than five years  
 
SECTION B: KNOWLEDGE OF HIV AND ART 
8. What does the HIV virus do in the body? * 
1. Kills your immune system  
2. Destroys your organs  
3. Causes TB  
4. Makes you stronger  
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9. Is HIV spread through any of the following?  * 
a. Kissing Yes No 
b. Hugging Yes No 
c. Sexual intercourse Yes No 
d. Mosquitoes Yes No 
e. Coughing Yes No 
f. Blood transfusion Yes No 
g. Contact with HIV positive blood or body fluids Yes No 
 
10. What is the window period? * 
1. When you get HIV through the air  
2. When HIV cannot be seen in the blood  
3. The time when you are safe to have sex without a condom  
4. Do not know  
 
11. How long does the window period last? * 
1. 3 months  
2. 6 months  
3. 9 months  
4. 1 year  
5. 2 years  
6. Do not  
 
12. What is a CD4 count? * 
1. The number of HIV cells in your blood  
2. The number of fighter cells in your blood which HIV likes  
3. The test done to determine whether you are HIV positive  
4. Do not know  
 
13. When last was your CD4 count done?  
1. Less than 6 months ago  
2. ≥6 months <  12 months ago  
3. ≥ 12 months to < 24 months  
4. > 24 months ago  
5. Do not know  
 
14. How often should you have your blood drawn for a CD4 count? * 
1. Every 6 months  
2. Every 12 months  
3. Every 24 months  
4. Every 60 months  
5. Do not know  
 
15. Why is it important to monitor your CD4 count?  
1. To monitor how many HIV cells you have in your blood  
2. To see if you have been cured of HIV  
3. To see if the HIV treatment is working  
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4. Do not know  
 
16. What is a viral load?  
1. Is the amount of HIV cells in your blood  
2. The transfer of HIV to your partner  
3. The number of immune cells in your blood  
4. Do not know  
 
17. When last was your blood drawn for viral load?  
1. Less than 6 months ago  
2. ≥6 months to <12 months  
3. ≥12months  to ≤24 months  
4. > 24 months ago  
5. Do not know  
 
18. Do you know what stage of HIV you are currently in? If yes, state which stage 
you are currently in 
No (n)  
Yes, I am in stage…  
 
19. If you are HIV positive, will your children also definitely be HIV positive?*  
Yes (y)  
No (n)  
 
20. Why did the staff at the clinic say that you must start treatment? 
............................................................................................................................................... 
21. Can ART cure HIV? * 
Yes (y)  
No (n)  
 
22. What does ART do to the HIV virus in the body? * 
1. Kills the virus  
2. Makes the HIV viral load less in the blood  
3. Makes it safe to have unsafe sex  
 
23. Did the clinic staff say that you can expect side-effects with the medication you 
are using? 
Yes (y)  
No (n)  
 
24. Can ART cause side effects that can be very dangerous? * 
Yes (y)  
No (n)  
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25. Can you name two danger signs? * (Must know at least 2.)* 
1. Skin rash  
2. Jaundice (yellow skin colour)  
3. Vomiting  
4. Do not know  
 
26 What should you do if you experience any of the danger signs? * 
1. Skip one day of medication and continue the next day  
2. Carry on taking your medication until the symptoms go away  
3. Stop medication and go to the clinic as soon as you can  
 
27 If you forget to take your medication, what should you do? * 
1. Drink it immediately when you remember  
2. Throw away tablet that was skipped and carry on  
3. Stop medication completely  
4. Take missed tablet/s together with your next dose  
 
28. What will happen if you stop taking your medication? * 
1. Nothing will happen  
2. Your medication may become less effective and HIV will increase in you  
3. You will be cured of HIV  
4. Do not know  
 
29. From where did you learn most of the knowledge about HIV and its treatment 
from?   
1. The HIV sister at the 
clinic 
 
2. Posters in the clinic  
3. TV and Radio  
4. The internet  
5. Books in the clinic  
6. A family member or  
7. The doctor  
8. Other  
 
Thank you! 
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APPENDIX B: ETHICAL COMMITTEE APPROVAL LETTER 
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APPENDIX C: ETHICAL COMMITTEE APPROVAL LETTER 
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APPENDIX D: PGWC APPROVAL LETTER 
 Directorate: Tygerberg/Northern Substructure 
Cnr Frans Conradie & Mike Pienaar  
Bellville, 7530 
Tel: +27 21 918 1679 
Fax: +27 21 918 1768 
www.capegateway.gov.za 
 
 REFERENCE: LSB/ELS/08/11      
 ENQUIRIES:  Dr. LS Bitalo 
Dr Stellenberg  
Head of research 
Division of Nursing  
Faculty of Health Sciences 
Stellenbosch University 
Tygerberg Campus 
Cape Town  
Dear Dr Stellenberg 
Your e-mail dated 26/07/2011 hereby formally acknowledged. 
 
We formally give permission for student L Terblanche to do research at the Delft Community 
Health Centre as required for her studies.  Our office did inform the appropriate people and 
we do apologise for any inconvenience caused by the delay. 
 
The Delft Community Health Centre Manager is Mr J Van Heerden and he can be contacted 
at  
021 9542237.  Please note that during the month of August Mr M Horn will be standing in as 
facility Manager and he can be contacted on the same number. 
 
Yours sincerely 
 
 
 
 
Dr L Bitalo 
Director:  Northern/Tygerberg Sub-structure 
Date:  8 August 2011 
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APPENDIX E: LETTER OF INFORMED CONSENT 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT:  
The Knowledge About HIV/AIDS and Antiretroviral Treatment of Patients Receiving 
Antiretroviral Therapy. 
 
REFERENCE NUMBER: N11/02/056  
PRINCIPAL INVESTIGATOR: Lauren Terblanche 
ADDRESS: 21 Nice Street, Durbanville, 7550  
CONTACT NUMBER: 0845511588 
 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand. It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved. Also, your participation is entirely voluntary and you 
are free to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do agree 
to take part. 
 
This study has been approved by the Health Research Ethics Committee (HREC) at 
Stellenbosch University and will be conducted according to the ethical guidelines and 
principles of the international Declaration of Helsinki, South African Guidelines for Good 
Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
 
What is this research study all about? 
 The study will take place at Delft community health centre where 200 patients who 
are HIV positive and on ART will be asked to participate in the study. 
 The study aims to find out what knowledge HIV patients on ART have of HIV and 
ART. By finding this out, the researcher will be able to see how much patients 
understand, and if they don’t, what the reasons are for not understanding. By 
knowing this, I will be able to work out strategies to improve patient education in the 
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clinics. By having more knowledge and understanding, patients will exercise safer 
sex practices, adhere to their medication and prevent the transmission of HIV. 
 You will be required to answer a questionnaire anonymously by means of an 
interview with the researcher or trained fieldworker which will last a maximum of 20 
minutes. 
 Two hundred participants will be chosen randomly. If you are at the clinic on the day 
the researcher is there and you are willing and available to participate, then an 
interview will be held with you. 
 
Why have you been invited to participate? 
 You have been invited as you are above 18 years of age, are HIV positive and on 
ART in this specific Delft community. By answering this questionnaire, you are 
helping this study to be successful as your knowledge and understanding of HIV and 
ART is important to this study, and will help others in your community in the future. 
 
What will your responsibilities be? 
 You will be responsible to answer the questionnaire honestly, knowing that the 
information you provide will be very valuable only if it is honest. 
 
Will you benefit from taking part in this research? 
 Depending on what the study shows, if there is not enough understanding and 
knowledge about HIV and ART, strategies to improve knowledge and understanding 
will be made for educating patients in the future. This will lead more people to 
practice safe sex, drink their medication as they should and eventually help prevent 
the transmission of HIV/AIDS in the future. This study will therefore benefit the 
people in your community and also yourself. 
 
Are there any risks involved in your taking part in this research? 
 There is no risk for you as a participant. 
 
If you do not agree to take part, what alternatives do you have? 
 You may stop your participation at any time, you are not forced to take part. It is your 
own free will whether to take part or not. 
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Who will have access to your medical records? 
 The information you provide in the questionnaire will be treated as confidential and 
protected and only the researcher or trained fieldworker will have access to your 
personal details. The study will be presented in a printed thesis, but all participants’ 
identities will remain anonymous at all times. A statistician will have access to your 
anonymous questionnaire, as well as the researcher or fieldworker and supervisor. 
All consent forms will remain with the researcher or fieldworker, and no one else will 
have access to these documents.  
 
What will happen in the unlikely event of some form of injury occurring as a direct result of your 
taking part in this research study? 
 Not applicable 
 
Will you be paid to take part in this study and are there any costs involved? 
No you will not be paid to take part in the study. There will be no costs involved for you, if 
you do take part. 
 
Is there anything else that you should know or do? 
 You can contact Sr. Lauren Terblanche at tel. 0845511588 if you have any further 
queries or encounter any problems. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you have 
any concerns or complaints that have not been adequately addressed by your study 
registered nurse. 
 You will receive a copy of this information and consent form for your own records. 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled ‘The Knowledge About HIV/AIDS and Antiretroviral Treatment of Patients 
Receiving Antiretroviral Therapy’. 
 I declare that: 
 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
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 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
 .....................................................................  ..................................................................  
Signature of participant Signature of witness 
 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use a interpreter. (If an interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
 .....................................................................  ..................................................................  
Signature of investigator Signature of witness 
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Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of Xhosa. 
 We encouraged him/her to ask questions and took adequate time to answer 
them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
 
 
 .....................................................................  ..................................................................  
Signature of interpreter 
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APPENDIX F: AFRIKAANS DECLARATION 
Verklaring deur deelnemer 
 
Met die ondertekening van hierdie dokument onderneem ek, 
…….....................……….....……...……….., om deel te neem aan ’n navorsingsprojek getiteld 
‘Die kennis oor MIV/VIGS en Antiretrovirale Terapie van Pasiente Wat Antiretrovirale 
Terapie Ontvang’.  
Ek verklaar dat: 
 Ek hierdie inligtings- en toestemmingsvorm gelees het of aan my laat voorlees 
het en dat dit in ’n taal geskryf is waarin ek vaardig en gemaklik mee is. 
 Ek geleentheid gehad het om vrae te stel en dat al my vrae bevredigend 
beantwoord is. 
 Ek verstaan dat deelname aan hierdie navorsingsprojek vrywillig is en dat daar 
geen druk op my geplaas is om deel te neem nie. 
 Ek te eniger tyd aan die navorsingsprojek mag onttrek en dat ek nie op enige 
wyse daardeur benadeel sal word nie. 
 Ek gevra mag word om van die navorsingsprojek te onttrek voordat dit 
afgehandel is indien die studiedokter of navorser van oordeel is dat dit in my 
beste belang is, of indien ek nie die ooreengekome navorsingsplan volg nie. 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 2011. 
 
 .....................................................................  ..................................................................  
Handtekening van deelnemer Handtekening van getuie 
 
Verklaring deur navorser 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die inligting in hierdie dokument verduidelik het aan 
…………………….............................................……….. 
 Ek hom/haar aangemoedig het om vrae te vra en voldoende tyd gebruik het om 
dit te beantwoord. 
 Ek tevrede is dat hy/sy al die aspekte van die navorsingsprojek soos hierbo 
bespreek, voldoende verstaan. 
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 Ek ’n tolk gebruik het/nie ’n tolk gebruik het nie. (Indien ’n tolk gebruik is, moet 
die tolk die onderstaande verklaring teken.) 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 2011. 
 
 .....................................................................  ..................................................................  
Handtekening van navorser Handtekening van getuie 
Verklaring deur tolk 
 
Ek (naam) …………………………………...……………… verklaar dat: 
 
 Ek die navorser (naam) ……….............................…………………. bygestaan het 
om die inligting in hierdie dokument in Afrikaans/Xhosa aan (naam van 
deelnemer) ……………………………......................... te verduidelik. 
 Ons hom/haar aangemoedig het om vrae te vra en voldoende tyd gebruik het om 
dit te beantwoord. 
 Ek ’n feitelik korrekte weergawe oorgedra het van wat aan my vertel is. 
 Ek tevrede is dat die deelnemer die inhoud van hierdie dokument ten volle 
verstaan en dat al sy/haar vrae bevredigend beantwoord is. 
 
 
Geteken te (plek) ..............................…………….. op (datum) …………....……….. 2011. 
 
 .....................................................................  ..................................................................  
Handtekening van tolk Handtekening van getuie 
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APPENDIX G: XHOSA DECLARATION 
Isifungo somthathi‐nxaxheba 
Ngokuytyikitya ngezantsi, Mna …………………………………..…………. ndiyavuma 
ukuthatha inxaxheba kwisifundo sophando semfuzo esibizwa ngokuba ‘The Knowledge 
About HIV/AIDS and Antiretroviral Treatment of Patients Receiving Antietroviral 
Therapy’. 
Ndazisa ukuba: 
 
 Ndilufundile okanye ndalufunda olu lwazi kunye nefomu yemvumelwano kwaye 
ibhalwe ngolwimi endiliciko nendikhululekileyo kulo  
 Bendinalo ithuba lokuba ndibuze imibuzo kwaye yonke imibuzo yam iphendulwe 
ngokwanelisayo. 
 Ndiyakuqonda ukuba ukuthatha inxaxheba kolu phando kube kukuzithandela 
kwam kwaye andikhange ndinyanzelwe ukuba ndithathe inxaxheba. 
 Ndingakhetha ukusishiya isifundo naninina kwaye andisayi kohlwaywa okanye 
uqal’ ugwetywe nangayiphi indlela. 
 Usenokucelwa ukuba usishiye isifundo phambi kokuba siphele, ukuba ugqirha 
wesifundo okanye umphandi ukubona kuyinzuzo kuwe, okanye ukuba 
andisilandeli isicwangciso sesifundo, ekuvunyelenwe ngaso. 
 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2011. 
 
 .....................................................................  
Umtyikityo womthathi-nxaxheba   Umtyikityo wengqina 
 
Isifungo somphandi 
 
Mna (igama) ………………………………………………… ndiyafunga ukuba: 
 Ndilucacisile ulwazi olu kweli xwebhu ku-…………………..……………... 
 Ndimkhuthazile ukuba abuze imibuzo kwaye athathe ixesha elifanelekileyo 
ukuba ayiphendule. 
 Ndiyaneliseka kukuba uyakuqonda ngokwanelisayo konke okumalunga 
nophando okuxoxwe ngasentla. 
 Ndisebenzise/andisebenzisanga toliki. (Ukuba itoliki isetyenzisiwe kumele 
ityikitye isaziso ngezantsi. 
Stellenbosch University http://scholar.sun.ac.za
 99 
 
 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2011. 
 
 .....................................................................  ..................................................................  
Umtyikityo womphandi     Umtyikityo wengqina 
 
 
Isifungo setoliki 
 
Mna (igama) ………………………………………………… ndazisa ukuba: 
 
 Ndicende umphandi (igama) …………………………….. Ekucaciseni ulwazi olu 
lapha kweli xwebhu ku-(igama lomthathi-nxaxheba) …………………………….. 
ndisebenzisa ulwimi lwesiAfrikaans/lwesiXhosa. 
 Simkhuthazile ukuba abuze imibuzo kwaye athathe ixesha elifanelekileyo ukuba 
ayiphendule. 
 Ndimxelele eyona nto iyiyo malunga nokunxulumene nam. 
 Ndiyaneliseka kukuba umthathinkxaxheba ukuqonda ngokupheleleyo 
okuqulathwe loluxwebhu lwemvumelwano eyazisiweyo kwaye nemibuzo yakhe 
yonke iphendulwe ngokwanelisayo. 
 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2011. 
 
 .....................................................................  ..................................................................  
Umtyikityo wetoliki Umtyikityo wengqina 
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